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ABSTRACT 
Application and Modeling of Frequency-domain Lifetime Spectroscopy for 
Microsphere-based Optical Glucose Sensors. (December 2006) 
Feng Liang, B.S., China University of Petroleum; 
M.S., China University of Petroleum 
Chair of Advisory Committee: Dr. Eva Sevick-Muraca 
 
A new glucose affinity sensor based on a homogeneous fluorescence resonance 
energy transfer (FRET) assay system was developed to monitor the competitive binding 
between concanavalin A (ConA) and dextran.  The FRET quenching kinetics of the 
donor were analyzed from frequency-domain (FD) measurements as functions of both 
glucose and acceptor-protein concentrations using a Förster-type decay kinetics model.  
The results showed that the FD measurements and donor decay kinetics can indicate 
quantitative changes in the presence of glucose at concentrations ranging from 0 to 224 
mg/dL. 
The second set of experiments proved the feasibility of performing analyte 
sensing with FD lifetime spectroscopy using microsphere-based sensors in multiple 
scattering solutions.  A well characterized pH-sensitive fluorophore was entrapped in 
poly(ethylene glycol) microspheres.  The particles were then immersed in a buffered 
polystyrene solution of various pH.  Measurements of phase shift and modulation of the 
generated and multiply scattered fluorescent light were acquired as the modulation 
frequency of the incident excitation light varied from 10 to 120 MHz.  After the 
 iv
measured data were analyzed with the coupled diffusion equations, the obtained 
lifetimes from the scattering measurements matched values from non-scattering 
measurements.  
Lastly, a new two-speed Monte Carlo (MC) simulation was developed to predict 
light propagation through the sensors and thus was used to evaluate these sensors and to 
design these sensors for implantation.  The model used random packing structure and 
considered geometric optics and two light propagation speeds.  Experimental 
measurements of phase-shift and modulation of excitation light were made on a cubic 
phantom with non-fluorescent resin microspheres of 74 µm diameter, and compared to 
those computed from the MC simulation.  The results showed that the mean phase shift 
(PS) deviation was 0.736˚ and the mean amplitude deviation was 42%.  Quantitative 
changes in detected fluorescence phase-shift and modulation were investigated for 
microsphere diameter, volume fraction, refractive index, and fluorophore lifetime.  We 
also found that even though the sensitivity of PS change in the presence of scattering 
was the same as the value without scattering, the values of PS were magnified due to the 
scattering effects. 
 v
DEDICATION 
 
 
 
 
 
 
 
 
 
 
To my parents, my wife, and my son 
 vi
ACKNOWLEDGMENTS 
There are lots of people I would like to thank who contributed directly or 
indirectly to the completion of my thesis. 
First, I wish to thank my advisor, Dr. Eva Sevick-Muraca.  She is one of the most 
respected professors whom I have had the opportunity to interact with and learn from.  
Her continued support and encouragement allowed me to pursue several areas of 
research that I have found very interesting. 
I wish to express my sincere appreciation to my previous and current committee 
members for their guidance and support throughout the course of this research.  They are: 
Dr. Michael Bevan, Dr. Friedhelm Schroeder, Dr. Mahmound El-Halwagi, Dr. Chun Li, 
and Dr. Babara Atshaves. 
I wish to thank Mrs. Xiaoxia Wen and Dr. Avery McIntosh.  I also wish to thank 
the following people from Electrical Engineering, Chemistry, and Biochemistry 
departments at Texas A&M University: Huiliang Zhang, Dr. Xiangshi Tan, Dr. Tinglu 
Yang, Dr. Mauricio Lasagna, and Dr. Liqun Gu.  My research gave me the opportunity 
to talk with those intelligent people. 
I wish to thank all my colleagues at the Photon Migration Laboratory, especially 
Drs. Eddy Kuwana, Yingqing Huang, Jessica Houston, Alan Thompson, Michael 
Gurfinkel, Anu Godavarty, Amit Joshi, Zhigang Sun, Dali Sarabjyot, and John 
Rasmussen.  Working with my group members, I improved my communication skills 
and learned many new research techniques. 
 vii
I am especially grateful to Dr. Tianshu Pan for our successful collaboration.  He 
is the smartest person I ever met. 
I wish to thank Towanna Hubacek and the Chemistry Department at Texas A&M 
University for providing help and support throughout my studies and research.  I also 
wish to thank the Radiology Department at Baylor College of Medicine for providing 
support for my last year of research.  Especially, I wish to thank Dr. Kristen Adams, Dr. 
Shi Ke, and Jessica Nollkamper at the Division of Molecular Imaging. 
Finally I wish to thank my parents, my parents-in-law, and my wife.  They have 
always inspired and supported me, especially through my Ph.D. work.  Without them, I 
could not have successfully completed my Ph.D. 
 viii
TABLE OF CONTENTS 
                        Page 
ABSTRACT ..................................................................................................................... iii 
DEDICATION ...................................................................................................................v 
ACKNOWLEDGMENTS.................................................................................................vi 
TABLE OF CONTENTS ............................................................................................... viii 
LIST OF FIGURES..........................................................................................................xii 
LIST OF TABLES .........................................................................................................xvii 
1. INTRODUCTION..........................................................................................................1 
1.1 Motivation ...............................................................................................................1 
1.1.1 The Importance of Continuous Glucose Sensing..........................................1 
1.1.2 Fluorescence Lifetime Spectroscopy as an Emerging Tool for Glucose 
Sensing...........................................................................................................3 
1.1.3 Implantable Polymer Microsphere-based Glucose Sensors ..........................6 
1.1.4 Using Protein-dextran Affinity System and FRET to Measure Glucose 
Concentration.................................................................................................8 
1.2 Goals of the Research..............................................................................................9 
1.3 Organization of Dissertation..................................................................................10 
2. BACKGROUND: OPTICAL GLUCOSE SENSING TECHNIQUES, FRET 
THEORY, AND CONA-DEXTRAN AFFINITY SYSTEM ......................................13 
2.1 Optical Techniques Used to Monitor Glucose Concentration in vivo ...................13 
2.1.1 Non-fluorescence Glucose Sensors .............................................................17 
2.1.1.1 Light Scattering Methods.................................................................17 
2.1.1.2 NIR Spectroscopy ............................................................................18 
2.1.1.3 Photonic Crystal Method .................................................................19 
2.1.1.4 Polarimetric Method ........................................................................20 
2.1.1.5 Photoacoustic Spectroscopy.............................................................21 
2.1.2 Fluorescence-based Glucose Sensor ...........................................................22 
2.1.2.1 GBP based Glucose Sensing System ...............................................23 
2.1.2.2 Apo-glucose Oxidase and Glucokinase Sensors..............................24 
2.1.2.3 Boronic Acid-based Glucose Sensors..............................................24 
2.1.2.4 Nanoparticle or Nanotube-based Glucose Sensors ..........................26 
2.2 Review of FRET Theory and FRET Application in Glucose Sensing..................28 
 ix
                        Page 
2.2.1 Simplified FRET Theory.............................................................................28 
2.2.2 Summary of FRET Application in Glucose Sensing ..................................34 
2.3 ConA-dextran FRET Affinity Sensor....................................................................40 
2.3.1 Properties of ConA and Dextran .................................................................40 
2.3.2 ConA-dextran Affinity System ...................................................................41 
3. METHODS: FLUORESCENCE DECAY KINETICS, LIGHT PROPAGATION 
IN FDPM......................................................................................................................44 
3.1 Fluorescence Decay Kinetics with and without FRET Process ............................44 
3.1.1 Fluorescence Decay Kinetics without FRET ..............................................44 
3.1.2 FRET Decay Kinetics..................................................................................44 
3.2 Measurement of Fluorescence Decay Kinetics with or without FRET.................49 
3.3 Decay Kinetics Analysis in Non-scattering and Scattering Solutions...................52 
3.3.1 Decay Kinetics Analysis in Non-scattering Solutions ................................52 
3.3.2 Decay Kinetics Analysis in Scattering Solution .........................................58 
3.3.2.1 Optical Diffusion Equation and Generated Fluorescence Photon 
Density .........................................................................................................58 
3.3.2.2 Relationships between Photon Density and Measurable Quantities 
(θM and mM)..................................................................................................62 
4. MEASUREMENTS OF FRET IN A GLUCOSE-SENSITIVE AFFINITY 
SYSTEM WITH FREQUENCY-DOMAIN LIFETIME SPECTROSCOPY .............64 
4.1 Introduction ...........................................................................................................64 
4.2 Materials and Methods ..........................................................................................66 
4.2.1 Donor-dextran/acceptor-ConA Affinity System. ........................................66 
4.2.2 Excitation and Emission Spectra.................................................................67 
4.2.3 Frequency-domain Lifetime Spectroscopy Measurements. ........................68 
4.2.4 Optimization of FRET Affinity System. .....................................................69 
4.2.5 Evaluations of FRET Decay Kinetics from Frequency-domain 
Measurement................................................................................................70 
4.3 Results ...................................................................................................................71 
4.3.1 Donor and Acceptor Characterization.........................................................71 
4.3.2 Optimization of the ConA and Dextran Affinity System............................74 
4.3.3 FD Measurements of FRET Changes with Adding Acceptor-ConA and 
Glucose ........................................................................................................77 
4.3.4 FRET Decay Kinetics of Donor-dextran in Response to Increasing 
Acceptor-ConA and Glucose Concentrations..............................................80 
4.4 Summary................................................................................................................88 
5. MICROSPHERE-BASED IMPLANTABLE OPTICAL SENSORS FOR PH...........89 
 x
                        Page 
5.1 Introduction ...........................................................................................................89 
5.2 Materials and Methods ..........................................................................................92 
5.2.1 Dyes and Solutions......................................................................................92 
5.2.2 Synthesis of SNAFL-ConA.........................................................................93 
5.2.3 Immobilization of SNAFL-ConA into Clear PEG Hydrogel......................93 
5.2.4 Phase Shift and Modulation Measurements ................................................97 
5.2.5 Measurements in Non-scattering Solutions.................................................98 
5.2.6 Measurements in Scattering Solutions ........................................................99 
5.3 Results and Discussions ......................................................................................101 
5.3.1 Fluorescence Multi-exponential Decay in Non-scattering Solutions........101 
5.3.2 Model Predictions of Multi-exponential Lifetime Decay in Scattering 
Polystyrene Solutions.................................................................................102 
5.4 Summary..............................................................................................................108 
6. MONTE CARLO MODELING OF FLUORESCENCE PHOTON MIGRATION 
IN MICROSPHERE-BASED IMPLANTABLE SENSORS ....................................109 
6.1 Introduction .........................................................................................................109 
6.2 Materials and Methods ........................................................................................118 
6.2.1 Phantom and Microsphere Structure for MC Simulation..........................118 
6.2.2 Descriptions of the MC Model with Geometric Optics ............................119 
6.3 Experimental Section...........................................................................................125 
6.3.1 Materials....................................................................................................125 
6.3.2 Phantom for Implantable Optical Sensors.................................................126 
6.3.3 FDPM Experiments...................................................................................127 
6.4 Results and Discussions ......................................................................................130 
6.4.1 FDPM Experimental Validation of the MC Model...................................130 
6.4.2 MC Computational Results for Fluorescence ...........................................136 
6.4.2.1 Influence of Microsphere Size .......................................................136 
6.4.2.2 Influence of Refractive Index of Microspheres .............................141 
6.4.2.3 Influence of Volume Fraction........................................................145 
6.4.2.4 Influence of Fluorescence Average Lifetime.................................147 
6.5 Summary..............................................................................................................150 
7. CONCLUSIONS AND FUTURE WORK ................................................................151 
7.1 Conclusions .........................................................................................................151 
7.2 Future Work.........................................................................................................152 
REFERENCES...............................................................................................................154 
APPENDIX   NOMENCLATURE ................................................................................169 
 xi
                        Page 
VITA ..............................................................................................................................175 
 xii
LIST OF FIGURES 
              Page 
Figure 1.1.  The molecule structure of glucose in aqueous solution. ............................2 
Figure 1.2.  Jabłoński diagram illustrating absorption, fluorescence and non-
radiative relaxation and collisional quenching, where κr and κnr 
correspond to the rate of radiative and non-radiative relaxation................5 
Figure 1.3.  A potential scheme for continuous glucose sensing using 
fluorescence and implantable polymer microspheres. ...............................8 
Figure 1.4.  Organization of the dissertation. ..............................................................12 
Figure 2.1.  The various optical glucose sensing techniques reviewed in this 
section.......................................................................................................16 
Figure 2.2.  Illustration of the process of FRET (upper figure) and Jabłoński 
diagram (lower figure) illustrates the FRET process. ..............................29 
Figure 2.3.  The absorption spectra of QSY21 (the dashed line) and the 
emission spectra of AF647 (the solid line) in PBS buffer (pH= 
7.2)............................................................................................................31 
Figure 2.4.  Dependence of FRET efficiency on the distance between D and A. .......34 
Figure 2.5.  ConA-dextran affinity sensing system in presence of glucose in 
solution. ....................................................................................................42 
Figure 3.1.  Illustration of time-domain (upper figure) and FD (lower figure) 
to measure fluorescence decay kinetics with or without the 
presence of FRET.....................................................................................50 
Figure 3.2.  Frequency-domain lifetime measurement in (a) non-scattering 
solution; and (b) scattering solution. ........................................................54 
Figure 3.3.  Phase shift change (upper figure) as the function of modulation 
frequency at different fluorescence lifetimes. Modulation (lower 
figure) as the function of modulation frequency at different 
fluorophore lifetimes. ...............................................................................55 
Figure 3.4.  Illustration of fluorescence light propagation in scattering media. ..........59 
 xiii
              Page 
Figure 4.1.  Normalized excitation (dashed line) and fluorescence (dashed 
dotted line) spectra of AF568-dextran (donor-dextran) and the 
normalized absorption (solid line) and fluorescence (dotted line) 
spectra of AF647-ConA (acceptor-ConA). ..............................................72 
Figure 4.2.  Donor (left) and acceptor (right) fluorescence intensity change 
(a.u.) at 602 and 680 nm resulting from excitation at 568 nm as a 
function of glucose concentration (mg/dL). .............................................75 
Figure 4.3.  Normalized donor fluorescence intensity (a.u.) at 602 nm 
following excitation at 568 nm as a function of donor-dextran 
concentration (×100 µM)..........................................................................76 
Figure 4.4.  The phase-shift (degrees) at 110 MHz of donor emission at 600 
nm in response to excitation at 568 nm as a function of glucose 
concentration (mg/dL)..............................................................................77 
Figure 4.5.  The phase-shift (degree) at 600 nm in response to excitation at 
568 nm as a function of modulated frequency (MHz) with 
increasing acceptor-ConA concentrations as indicated in the 
legend. ......................................................................................................78 
Figure 4.6.  The modulation ratio at 600 nm in response to excitation at 568 
nm as a function of modulated frequency (MHz) with increasing 
acceptor-ConA concentrations as indicated in the legend. ......................79 
Figure 4.7.  The phase-shift (degree) at 600 nm in response to excitation at 
568 nm versus modulation frequency (MHz) as a function of 
increasing glucose concentration (mg/dL) as indicated in the 
legend. ......................................................................................................81 
Figure 4.8.  The modulation ratio at 600 nm in response to excitation at 568 
nm versus modulation frequency (MHz) as a function of 
increasing glucose concentration (mg/dL) as indicated in the 
legend. ......................................................................................................82 
Figure 4.9.   Parameter estimates of (a) γ (dimensionless), (b) β (dimensionless) 
and (c) α (ns) as a function of acceptor-ConA concentration, based 
on the concentration of dextran is equal to 0.09 µM................................83 
Figure 4.10.  Parameter estimates of (a) γ (dimensionless), (b) β (dimensionless), 
and (c) α (ns) as a function of glucose concentration, based on the 
concentration of dextran is equal to 0.09 µM and the concentration 
of ConA is equal to 10.67 µM respectively..............................................86 
 xiv
              Page 
Figure 5.1.  Hydrogel preparation set-up where droplets of precursor solution 
were extruded through a syringe pump, sprayed with compressed 
air resulting into fine droplets that fell into mineral oil bath, and 
photopolymerized upon exposure to UV light at 365nm. ........................95 
Figure 5.2.  (Top figure) PEG microspheres under Nikon microscope and 
(Bottom figure) size distribution of the PEG microspheres. ....................96 
Figure 5.3.  Excitation (emission at 570 nm) and emission (excitation at 514 
nm) spectra of C-SNAFL-1 ester, SNAFL-ConA, and SNAFL-
PEG in PBS (pH 7.2)..............................................................................102 
Figure 5.4.  The values of  fluorescence phase-shift, as a function of 
modulation frequency for SNAFL-PEG, where the plots in each 
figure consist of corrected experimental measurements (dotted 
lines) in non-scattering (bottom) and scattering solution (top) at 
various pH, and those predicted by the propagation model 
incorporating average lifetime (solid lines). ..........................................104 
Figure 5.5.  The values of modulation-ratio, as a function of modulation 
frequency for SNAFL-PEG, where the plots in each figure consist 
of corrected experimental measurements (dotted lines) in non-
scattering (bottom) and scattering solution (top) at various pH, 
and those predicted by the propagation model incorporating 
average lifetime (solid lines). .................................................................105 
Figure 5.6.  Average standard deviation of phase-shift data in non-scattering 
and scattering, calculated over a range of modulation frequencies 
from 30 to 130 MHz in 5 MHz increments with 3 measurements 
replicates experiment, at each pH value.................................................107 
Figure 6.1.  Illustration of light propagation in large, densely-packed 
microspheres with significant refractive index difference with skin 
layers. .....................................................................................................116 
Figure 6.2.  Flowchart of MC simulation ..................................................................121 
Figure 6.3.  Schematic of the phantom for implantable cubic phantom used in 
MC simulation........................................................................................124 
Figure 6.4.  Resin microspheres under Nikon microscope. .......................................125 
Figure 6.5.  Size distribution of the resin microspheres. ...........................................126 
 xv
              Page 
Figure 6.6.  Schematic of source and detection fibers’ position on the 
phantom.. ................................................................................................127 
Figure 6.7.  (Top) Schematic of FDPM instrumentation set up.  (Bottom) 
picture of the set-up for resin measurements. ........................................129 
Figure 6.8.  (Top) Excitation Phase-shifts and amplitudes at different 
modulation frequency (70 MHz and 100MHz) as the function of 
detector position on the detection surface (shown in Figure 6.6). .........131 
Figure 6.9.  (Top) Excitation Phase-shifts and amplitudes at different 
modulation frequency (70 MHz and 100MHz) as the function of 
detector position on the detection surface (shown in Figure 6.6). .........132 
Figure 6.10.  Phase shift deviation δθ (degree) at different modulation 
frequencies (70-100MHz) as the function of sixty detector 
position on the surface............................................................................134 
Figure 6.11.  AC deviation δAC (%) at different modulation frequencies (70-
100MHz) as the function of sixty detector position on the surface........135 
Figure 6.12.  Simulation results of fluorescence phase shift θf (radius) versus 
microsphere diameter (µm) at different detection position and 
different modulation frequencies (MHz)................................................138 
Figure 6.13.  Simulation results of normalized fluorescence amplitude ACf (a.u) 
versus microsphere diameter (µm) at different detection positions 
and different modulation frequencies (MHz).........................................139 
Figure 6.14.  Simulation results of fluorescence phase shift θf (radius) as a 
function of 1/sqrt (dpar (in diameter, µm)) at different detection 
position and different modulation frequency (MHz). ............................140 
Figure 6.15.  Simulation results of fluorescence phase shift θf (radius) as a 
function of refractive index of microspheres at 100MHz and at 
detection position 4. ...............................................................................142 
Figure 6.16.   Simulation results of normalized fluorescence amplitude ACf (a.u.) 
as a function of refractive index of microspheres at 100MHz and 
at detection position 4. ...........................................................................143 
Figure 6.17.  Simulation results of θf at different detector positions with 
increasing volume fraction of microspheres in the cubic phantom 
at modulation frequency of 70 MHz. .....................................................146 
 xvi
              Page 
Figure 6.18.  Simulation results of ACf at the function of volume fraction of 
microspheres in the cubic phantom at modulation frequency of 70 
and 100 MHz. .........................................................................................147 
Figure 6.19.  Simulation results of fluorescence phase shift θf (radius) as a 
function of fluorophore average lifetime at 100 MHz and 
detection position 4. ...............................................................................148 
Figure 6.20.  Simulation results of normalized fluorescence amplitude ACf (a.u.) 
as a function of fluorophore average lifetime at 100MHz 
modulation frequency and detection position 4. ....................................149 
 
 xvii
LIST OF TABLES 
              Page 
Table 2.1.  A summary of the effect of glucose concentration change upon 
measured optical properties of tissues, measured diffraction signal, 
and measured Raman intensity.................................................................15 
Table 2.2.  Review of literature involving glucose sensing based on FRET 
competitive-binding affinity system*. ......................................................35 
Table 2.3.  Association constants of  some sugar molecules to ConA (49) ..............40 
Table 3.1.  Overview of fluorescence decay kinetics model without presence 
of FRET in non-scattering solution. .........................................................45 
Table 3.2.  Summary of FRET decay kinetics models in homogenous, non-
scattering medium. ...................................................................................48 
Table 4.1.  Fluorescence properties for different donor-acceptor FRET pairs 
used in our experiments and other literature: ...........................................73 
Table 4.2.  Comparison of the change of donor average lifetime and the 
change of parameter γ with (a) increasing acceptor-ConA 
concentration; (b) increasing glucose concentration. ...............................84 
Table 5.1.  Average lifetime values calculated from phase-shift data (τavgscat) 
and from the repeated experimental data (τavgscat (repeat))  in 
presence of scattering, assuming two-exponential decay kinetics, 
at a fixed frequency of 100 MHz, in comparison with the values 
obtained in dilute non-scattering solutions (τavg). ..................................106 
Table 6.1.  Review of literature involving microsphere-based fluorescence 
glucose sensor ........................................................................................111 
Table 6.2.  The refractive index of different skin layers, polymer 
microspheres and TiO2. ..........................................................................115 
Table 6.3.  Details of physical properties of resin samples ......................................126 
Table 6.4.  List of averages of δPS and δAC at different modulation 
frequencies. ............................................................................................135 
Table 6.5.  Simulation conditions for the study of particle size influence on θf  
and amplitude ACf. .................................................................................137 
 xviii
                        Page 
Table 6.6.  Simulation conditions for the study of refractive index influence 
on θf  and amplitude ACf. ........................................................................141 
Table 6.7.  Simulation conditions for the study of volume fraction influence 
on θf  and amplitude ACf. ........................................................................145 
Table 6.8.  Simulation conditions for the study of the influence of fluorophore 
lifetime on θf  and amplitude ACf............................................................149 
 
1 
1. INTRODUCTION  
1.1 Motivation 
1.1.1 The Importance of Continuous Glucose Sensing  
The daily routine for a diabetes patient currently involves pricking the skin and 
drawing blood 4 to 8 times a day measure the blood glucose level.  According to the 
Centers for Disease Control and Prevention, 20.8 million people, or about 7% of the total 
population in the U.S. had either type I or type II diabetes in 2005 (1) . The World 
Health Organization estimates the number of diabetes patients worldwide to be 300 
million by the year 2025 (2).  Currently, diabetics are directly treated by either pancreas 
transplantation or islet cell transplantation.  There are many technical difficulties 
associated with both approaches, such as transplantable organ shortage, immune 
complications, and organ or cell failure (3).  The recent interest in stem cell research has 
attracted public interest but the hope of large scale, cell-based treatment of diabetes has a 
long way from fruition (4).  An alternative approach to treat diabetes is based upon the 
idea of an artificial beta cell (5).  The artificial beta cell could measure glucose 
concentration and then automatically deliver insulin needed.  Therefore, the most 
important component of the artificial beta cell is the continuous glucose-sensing unit. 
___________ 
 This dissertation follows the style of Photochemistry and Photobiology. 
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Continuous glucose monitoring would allow diabetics to immediately, accurately, 
and conveniently control their glucose levels, thereby reducing the most serious 
complications of diabetes, including heart disease, blindness, amputations of extremities, 
and early death.  Diabetes has an annual economic cost in the U.S. of more than 132 
billion dollars, making the continuous glucose sensor the “holy grail” of all biomedical 
sensor development efforts.  
Glucose is represented as C6H12O6.  It has a molecular weight (MW) of 180 Da 
and a molecular size less than 5 Å.  In solution, the molecules are not open chains but 
rings as shown in Figure 1.1 (6).  Glucose levels in normal blood range from 90 mg/dL 
to 120 mg/dL (7,8)).  In diabetes, blood glucose levels may fluctuate between 40 mg/dL 
and 400 mg/dL (8).  The “gold standard” for glucose measurement requires the patient to 
extract a drop of blood (typically by pricking the fingertip or the forearm).  The glucose 
in the blood reacts with the oxygen in the air and is catalyzed by the glucose oxidase 
(GOX) enzyme to produce hydrogen peroxide.  The hydrogen peroxide is then detected, 
providing an indirect measurement of glucose concentration.   
2 2 2 2
GOXD glucose O H O D gluconate H O− + + ⎯⎯⎯→ − +                        (1.1) 
 
 
 
Figure 1.1. The molecule structure of glucose in aqueous solution. 
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The finger-pricking enzymatic measurement method consumes blood and has 
several severe limitations such as low accuracy, constant calibration, poor compliance 
from diabetic patients, and most importantly, the inability to continuously monitor 
changing glucose levels.  It has been reported that a tighter control of blood glucose in 
insulin-dependent diabetics could reduce the severity of long-term complications such as 
retinopathy, nephropathy, and neuropathy (9).  Therefore, a new glucose monitoring 
system capable of continuous measurement is needed.  Currently the three commercially 
available mini-invasive glucose sensors which perform continuous monitoring based on 
enzymatic analysis, are: MiniMed-Medtronic Continuous Glucose Monitoring System 
(CGMS) (Northridge, CA, USA); GlucoWatch biographer (Animas, West Chester, PA), 
and GlucoDay microdialysis system (Menarini, Medulla, Italy).  None of these systems 
are adequate due to a lack of biocompatibility and significant signal drifts (10,11).   
1.1.2 Fluorescence Lifetime Spectroscopy as an Emerging Tool for Glucose Sensing 
A number of minimally invasive or noninvasive techniques have been 
investigated for glucose monitoring during the last decades.  The optical sensing 
methods which are promising for physiological glucose sensing include near-infrared 
(NIR) absorption spectroscopy (12-14), Raman spectroscopy (15), surface plasmon 
spectroscopy (16-18), polarimetric measurement of eye fluids (19), light scattering 
measurement (20-22), optical coherence tomography (OCT, (23)), and fluorescence 
spectroscopy (24,25).  In Section 2.1, a review of optical glucose sensing techniques is 
provided. 
4 
In light of the difficulties associated with conventional glucose meters, 
fluorescence spectroscopy may provide a feasible and robust way to create a new type of 
implantable glucose sensor (7).  The concept of fluorescence is shown in the Jabłoński 
diagram at Figure 1.2.  The fluorophore lifetime, τ0, which is typically on the order of 
10-9 seconds, is defined as the average time the fluorophore spends in its excitation state 
and is shown mathematically as Equation 1.2:  
0
1
nr r
τ κ κ= +                                              (1.2) 
 
where the κnr and κr refer to the rate of non-radiative relaxation and radiative relaxation 
of the fluorophore. The fluorescence quantum efficiency Q is defined as the ratio of the 
number of fluorescent photons emitted to the number of excitation photons absorbed by 
the fluorophore:   
   1
1 nr
r
Q κ κ
=
+
      (1.3) 
Both lifetime and quantum efficiency of fluorophores are known to be sensitive 
to the local biological and chemical environments (26).  There are many intra- and 
intermolecular interactions which influence the fluorophore lifetime such as collision 
quenching and FRET.  Therefore the measured fluorescence lifetime τ is usually shorter 
than τ0. Thus the measured fluorescence lifetime is the inverse of the total rate of all 
relaxation processes that cause deactivation from the excitation state.   
 
5 
Figure 1.2. Jabłoński diagram illustrating absorption, fluorescence and non-radiative 
relaxation and collisional quenching, where κr and κnr correspond to the rate of radiative 
and non-radiative relaxation.  The term κq is the Stern-Volmer constant for collisional 
quenching . [Cq] is the quencher concentration.  S0 is the electronic ground state and S1 
is the first excited singlet state.  Adapted from Richards-Kortum and Sevick-Muraca (27). 
 
 
 
In the presence of collisional quenching and FRET, the measured fluorescence 
lifetime is given as Equation 1.4: 
1
nr r T q qC
τ κ κ κ κ= ⎡ ⎤+ + + ⎣ ⎦
    (1.4) 
where the κq is the Stern-Volmer constant; κT refers to the rate of FRET; and [Cq] is the 
quencher concentration.  
While the fluorescence intensity measurements are technologically simple and 
straightforward, they can suffer from distortion of emission spectra because of the 
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wavelength dependent scattering and absorption properties of tissues.  Fluorescence 
lifetime measurement provides more intrinsic advantages as compared to fluorescence 
intensity measurement. The lifetime measurement is not influenced by fluorophore 
photobleaching (28), fluorophore concentration fluctuation (29), and instrumentation 
artifacts (30).  Lifetime-based chemical sensing has been proposed by several groups for 
the quantitation of pO2 (31), pH (32) , Ca2+ (33), Cu+ (34), Zn2+ (35), and other 
metabolites. 
For a sensor implanted in tissue, scattering and absorption of tissue will attenuate 
the intensity of the fluorescent signal and add nanosecond “time-of-flight” to the photon 
propagation in the tissue (27).  Both signal attenuation and photon “time-of-flight” must 
be accounted for in order to achieve quantitative in vivo analyte sensing in tissue.  
Fluorescence lifetime measurements can be made independently of tissue scattering and 
absorption properties (36).  Most importantly, previous work has shown that the 
combination of (i) fluorescence lifetime spectroscopy, (ii) models of fluorescence 
lifetime decay kinetics, and (iii) models of time-resolved light propagation enabled 
quantitative biomedical sensing in tissue phantoms (30).  In this work, the feasibility of 
using lifetime measurement to detect glucose concentrations within the physiological 
range is presented. 
1.1.3 Implantable Polymer Microsphere-based Glucose Sensors  
The idea of implantable glucose sensors was initially reported in 1974 by 
Alibisser et al. (37).  Drs. Cote and Pishko’s research groups first investigated using a 
“smart tattoo” consisting of small polymer microsphere-based implantable sensors for 
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monitoring glucose (38-42).  The idea was to physically or chemically immobilize the 
fluorophores and glucose-sensitive affinity system inside a polymer matrix for protection 
of the fluorophore.  The polymer protection also increased the stability of glucose 
sensitive affinity system in biological samples and decreased toxicity.  After the 
microsphere-based sensors were implanted in the skin, fluorescence intensity spectra 
were obtained by noninvasively scanning the skin surface and were analyzed for the 
glucose concentration (41).  Their results showed feasibility for qualitative glucose 
monitoring with fluorescence intensity measurements (40).  Initially in their study, 
alginate-poly-L-lysine microparticles were used.  Subsequent work employed PEG due 
to its biocompatibility and porous structure, which removed transport limitations.  
Recent experimentation has explored alternate polymer types, including Sephadex(43), 
Sepharose(44), polystyrene(45,46), and polyelectrolyte-coated alginate microbeads 
(38,47).  All of these studies measured changes in fluorescence intensity with glucose 
concentration.  The work presented in this dissertation sought to measure florescence 
lifetime changes arising from physiological glucose concentrations in a microsphere-
based sensor.  Figure 1.3 illustrates a possible scheme for implantable polymer 
microsphere-based, fluorescence glucose sensors. 
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Figure 1.3. A potential scheme for continuous glucose sensing using fluorescence and 
implantable polymer microspheres.  In this case, a portable continuous detector provides 
laser light and detects the fluorescence signal change with glucose level in the interstitial 
fluid.  The polymer microspheres are implanted underneath the skin.   
 
 
 
1.1.4 Using Protein-dextran Affinity System and FRET to Measure Glucose 
Concentration 
Many efforts to develop noninvasive glucose sensors have focused upon the 
ConA–dextran affinity system for FRET-based sensing of glucose as an alternative to 
conventional enzymatic glucose sensors (24,32,40,41,44,48-54).  In this scheme, the 
sugar-binding plant lectin, ConA, is labeled with fluorescent dyes acting either as donor 
or acceptor and competitively binds glucose and dextran (48,50).  Competitive binding 
can be followed if the dextran is also conjugated with a fluorescent dye which acts as the 
corresponding acceptor or donor.  The change of FRET between donor and acceptor due 
to competitive binding can be monitored to determine the concentration of glucose (48).  
For this affinity system, the acceptor, which itself might not necessarily be fluorescent 
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(50,51), has been labeled to either ConA or dextran without any clear advantage of one 
over another (44,50,51).   
1.2 Goals of the Research 
The goal of the research is to apply fluorescence lifetime spectroscopy to the 
development of an implantable, polymer microsphere-based optical sensor for glucose.  
Despite the current progress of development of polymer-based implantable glucose 
sensors (38,40,41,55,56), three elusive questions remain to be answered for the 
development of microsphere-based fluorescence implantable sensor: 
1. Could FD lifetime measurements be used to determine glucose concentration 
in the physiological range?  If so, what is the relationship between fluorescence decay 
kinetics and binding affinity? 
2. Could fluorescence lifetime sensing using frequency-domain photon migration 
(FDPM) techniques be applied to detect fluorescence lifetime for implantable glucose 
sensors in scattering tissues? 
3. How should the implantable polymer microsphere-based sensors be designed 
for lifetime measurement? 
The specific aims of this research are: 
1. To develop a new glucose-sensitive affinity system based upon FRET, then to 
measure the glucose concentration in non-scattering solution using FD lifetime 
spectroscopy, finally to assess changing FRET decay kinetics with glucose 
concentrations. 
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2. To explore the feasibility of fluorescence lifetime sensing in microsphere-
based implantable sensors in tissue-mimicking scattering phantoms. 
3. To develop and experimentally validate a new Monte Carlo model for light 
propagation in microsphere-based implantable sensors.  
1.3 Organization of Dissertation 
The flowchart in Figure 1.4 provides the sequences of sections and the topics 
presented. 
Section 2 provides a detailed review of various optical techniques used in 
glucose sensing and highlights the fluorescence spectroscopic methods.  The theories 
and application of FRET are introduced and previous applications of FRET 
measurements in glucose sensing are detailed.  Finally, an introduction to the glucose 
sensitive ConA-dextran affinity sensor is introduced and reviewed. 
In Section 3, time-dependent light propagation, its theory, and the incorporation 
of fluorescence decay kinetics are presented. 
Section 4 contains published work towards this thesis demonstrating 
measurement of FRET for a new glucose-sensitive affinity system and analysis of FRET 
decay kinetics (57). 
In Section 5, the results are presented for implantable pH sensors in the tissue-
mimicking scattering solution using FD lifetime measurement (58). 
Section 6 details the development of a new MC simulation of fluorescence light 
propagation capable of predicting fluorescence lifetime measurements.  The simulation 
method was experimentally validated in a resin-packed, three dimensional phantom.  
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Then the influence of optical/physical properties of the microspheres is discussed using 
the simulation results. 
In Section 7, the major results of the research are summarized and possible future 
studies are presented. 
12 
 
Figure 1.4. Organization of the dissertation. 
Section 2: Reviews of optical techniques used for glucose sensing, 
FRET theory and application in glucose sensing, and ConA-dextran 
affinity system
Section 3: Fluorescence decay kinetics and measurement 
Section 6:  Monte Carlo modeling of fluorescence photon migration in 
microsphere-based sensor
Section 5: Microsphere-based implantable sensors for pH 
“Fluorescence lifetime spectroscopy of a pH-sensitive dye encapsulated 
in hydrogel beads,” Biotechnology Progress, vol. 20, p. 1561-1566, 
2004. 
Section 4: Construction and measurement of FRET in a glucose-
sensitive affinity system 
“Measurements of FRET in a glucose-sensitive affinity system with 
Frequency-domain lifetime spectroscopy,” Photochemistry and 
Photobiology, vol. 81, p.1386-1394, 2005 
Section 1: Motivation, goals of research, and thesis organization 
Section 7: Summary of results and presentation of future work 
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2. BACKGROUND: OPTICAL GLUCOSE SENSING TECHNIQUES, FRET 
THEORY, AND CONA-DEXTRAN AFFINITY SYSTEM 
To preface the application of fluorescence lifetime spectroscopy in glucose 
sensing, a complete summary is provided below describing optical glucose sensing 
techniques, FRET theory and its application to glucose sensing, and the ConA-dextran 
affinity sensor.  
2.1 Optical Techniques Used to Monitor Glucose Concentration in vivo 
Optical techniques for glucose monitoring are promising and are one of the 
fastest growing biomedical areas because: (i) optical sensing may provide noninvasive 
measurements without detectors physically contacting the body, for patients leading to 
less pain and more convenience; (ii) fast reading of signal changes should allow 
continuous glucose monitoring; (iii) when used non-invasively, optical signal is not 
subject to ambient electrical interference; and (iv) optical sensors do not consume 
glucose or blood in the body. 
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Typically optical glucose measurement techniques focus on measuring the 
change in optical properties with change in blood glucose levels.  Change in blood 
glucose level will change the scattering coefficients, µs, isotropic or reduced scattering 
coefficient, µs’, the absorption coefficients of tissue, µa’, and polarization of the 
transmitted or backscattered light.  The isotropic or reduced scattering coefficient µs’ is 
define as: ( )' 1s s gµ µ= − , where the parameter g is the mean of the cosine of the 
scattering angle.   
Table 2.1 provides an overview of the influence of glucose concentration on 
measured tissue optical properties.  In this review, we classify the bulk of recent research 
on optical glucose sensing techniques into two different groups: (i) non-fluorescence 
glucose sensing optical methods, which include light scattering, NIR and Raman 
spectroscopy, photonic crystal method, OCT, and polarimetry; and (ii) fluorescence-
based glucose sensing optical methods.  The review of each technique will start by 
introducing its optical/physical principles, and discussing recent results and difficulties 
which still remain to be overcome.  The optical glucose monitoring techniques can be 
classified as shown in the following Figure 2.1. 
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Table 2.1. A summary of the effect of glucose concentration change upon measured 
optical properties of tissues, measured diffraction signal, and measured Raman intensity. 
 
Increasing glucose 
concentration  Methodology 
Change in absorption 
Water absorption 
coefficient µaw(λ)  ↓ 
Intrinsic glucose absorption 
coefficient µag(λ)  ↑ 
NIR and mid-IR 
spectroscopy Photoacoustic 
spectroscopy 
Change in scattering 
Scattering or Isotropic 
scattering coefficient g ↑ µs(λ) ↓ µs’(λ)  ↓ 
Light scattering 
measurements, OCT 
Change in polarization 
Observed rotation φ(λ) ↑ polarimetry 
Change in photonic crystal 
Observed diffraction Blue-shift ↑ (59) or red-shift ↑ (60) 
Photonic crystal 
measurement 
Change in Raman scattering 
Observed Raman Intensity Intensity ↑ Raman spectroscopy 
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Figure 2.1. The various optical glucose sensing techniques reviewed in this section. 
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2.1.1 Non-fluorescence Glucose Sensors 
2.1.1.1 Light Scattering Methods 
Light scattering methods rely on the refractive-index change caused by glucose 
concentration changes.  Therefore the measured optical isotropic scattering coefficient of 
tissue, µs’, changes with the concentration of glucose in the extracellular fluid.  For a 
simple model of scattering spherical particles, the isotropic scattering coefficient,  µs’ can 
be related to the refractive index of the scattering medium based on the Mie theory as 
shown in the following  equation (23,61):               
2.090.37
' 220.34 1ps p
m
nrr
n
µ ρ λ
⎛ ⎞⎛ ⎞= −⎜ ⎟⎜ ⎟⎝ ⎠ ⎝ ⎠
   (2.1) 
where r is the spherical particle radius; ρp is the volume density of the particles; λ is the 
wavelength of incident light; and np , nm are the refractive indices of particles and the 
medium.  Increased glucose concentration will increase the refractive index of the 
medium, nm and thus decrease the isotropic scattering coefficient. 
The refractive-index increment of an aqueous glucose solution ∆nm for visible 
wavelength is 2.5×10-5 /mM glucose (20-22).  By using polystyrene and lyposyn aqueous 
phantoms, two research groups have shown that the presence of glucose dissolved in an 
aqueous solution increased the refractive index of the solution and therefore influenced 
the scattering properties of particles suspended within it (20,21).  Kohl et al. measured 
the fractional change of the isotropic scattering coefficient ∆µs’ (cm-1) caused by glucose 
to be -0.016%/mM glucose (22).  Maier et al. demonstrated that the small change in 
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scattering coefficient made it difficult to measure glucose level in biological tissues due 
to confounding factors from other tissue substances and organelles, and blood glucose 
distribution.  He used a FD reflectance system on the thigh of a normal volunteer (21).  
Bruulsema et al. evaluated the sensitivity of the isotropic scattering coefficient for 
monitoring change of blood glucose levels in 41 diabetic volunteers (62).  They used a 
charged-coupled device (CCD) detection system to measure the tissue reflectance.  Their 
results showed qualitatively that they could relate tissue reflectance with blood glucose 
concentration on the patients.  However, the unclear drifts in measured µs’ prevented the 
quantitative correlation between µs’ and blood glucose level.   
Extensive work explored using OCT to measure the changes in scattering 
coefficient, µs (63).  This method was first studied in animals and then in healthy 
volunteers (64).  Larin et al. used OCT to measure scattering coefficient changes in the 
skin of Yucatan micropigs and New Zealand rabbits (23).  In the human study, a 
difference of 10 mg/dL glucose corresponded to 1.2-2% change in the slope of the linear 
fit of OCT signals (64). 
2.1.1.2 NIR Spectroscopy 
IN the last decade most of the research in this field has focused on NIR 
spectroscopy. This method has been used to extract glucose concentrations from 
reflectance or transmission spectra with wavelengths from 600 to 1300nm or even longer 
than 2µm.  This method is based upon the fact  that (i) increasing glucose concentration 
will increase the intrinsic absorption of glucose bands, and (ii) increasing glucose 
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concentration will decrease the intrinsic absorption of water bands by the volume 
displacement of water with glucose (65).  Using multivariate analysis techniques to relate 
NIR responses and glucose concentrations to the spectral changes, models can be derived 
in which there is a good correlation between NIR readings and blood glucose 
concentrations (12,14,66-69). Unfortunately, poor precision due to interference from 
several confounding factors such as (i) background noise, (ii) change of temperature, pH, 
and scattering, (iii) skin pigmentation, (iv) blood flow variation, and (v) probe placement 
and probe pressure have slowed clinical development.  Raman spectroscopy, based on the 
inelastic scattering of incident light, also has similar difficulties (70). 
2.1.1.3 Photonic Crystal Method 
The photonic crystal method involved diffraction of light from polymerized 
crystalline colloidal arrays (PCCAs) that swell with changes in glucose concentration 
(59,71).  The PCCA is polymerized within a hydrogel film that includes GOX or 
phenylboronic acids.  When GOX reacts with glucose or when the boronic acids 
reversibly bind glucose, the pH of the hydrogel is reduced and the hydrogel expands.  
The expansion caused an increase in the spacing between the spherical polystyrene 
colloids (~10 µm in diameter) bound to the hydrogel.  This caused the angle at which 
light is diffracted off of the spherical colloids to increase, enabling detection of glucose 
concentration changes (72).  The photonic crystal sensor was tested recently with 
artificial tear fluids and is intended to be worn as a contact lens (73).  The sensitivity and 
specificity of this sensor primarily depend on the glucose recognition group, which is 
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either GOX or boronic acid.  Therefore, it faced the similar problems as found with other 
GOX or boronic acid-based glucose sensing methods, as discussed below in section 2.1.2. 
2.1.1.4 Polarimetric Method 
The polarimetric method is based on the fact that glucose, as an optically active 
molecule, will rotate the plane of linearly polarized light passing through the solution 
(24).  The relationship between glucose concentration [C] and measured rotation φ(λ) in 
solution is shown as follows (65): 
( )
( )cos
1[ ] measuredglu e
specific
C
L
φ λ
φ λ=
      (2.2) 
where  φ(λ)specific is the specific rotation of the glucose at a given wavelength λ.  Αt 589 
nm, φ(λ)specific is equal to 52.6˚.  The term L is the path length, and φ(λ)measured is the 
observed rotation in degrees.  φ(λ)measured is also the function of temperature and pH. 
Within physiological concentrations and when the pathlength L is equal to 1 cm, 
glucose will rotate the linear polarization of a light beam about 0.4 millidegrees per 10 
mg/dL.  Cameron  et al. presented in vivo results from a laser-based optical polarimetry 
system using the anterior chamber of rabbit eyes to demonstrate the potential non-
invasive glucose monitoring method (19).  Challenges with polarimetric glucose sensing 
in the eye include other optical rotations due to the cornea, birefringence of the cornea, 
movement of the eyes, and the presence of other optically active components in the 
aqueous humor (7). 
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2.1.1.5 Photoacoustic Spectroscopy 
The photoacoustic technique involves the creation of acoustic wave by the 
absorption of light energy.  The ultrasonic pressure generates a pulse that propagates and 
can be detected by a piezoelectric detector (74).  For a weak absorbing sample, the 
generated pressure increase can be described by the following equation (75): 
2
a
P
vP
C
β µ⎛ ⎞∆ = Φ⎜ ⎟⎝ ⎠
     (2.3) 
 
where β is the coefficient of thermal expansion;  v is the speed of sound in the medium; 
Cp is the specific heat of the medium; Φ is the light fluence; and µa is the absorption 
coefficient of the medium.  As it can be seen from the above Equation 2.3, the pressure 
increase is the proportional to the absorption coefficient of the irradiated medium.  
Eqation 2.3 represents the principle of photoacoustic spectroscopy for glucose sensing.  
Mackenzie et al. reported in vitro and in vivo experimental photoaccoustic results using 
the wavelength range from 800 nm to 1200 nm (75).   Their in vitro experiments 
investigated the interference effects from sodium chloride, cholesterol, and bovine serum 
albumin and showed that they did not influence the photoacoustic signal due to the 
change of glucose concentration.  A study with 53 volunteers showed good correlation 
between the photoacoustic measurements and the measured blood glucose concentrations.  
Kinnunen et al. conducted photoacoustic measurement in 1% intralipid and whole blood 
of swine at the wavelengths of 532 nm and 1064 nm (74).  The sensitivity of 
photoacoustic signals to change in glucose concentration was higher in blood samples 
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(11.4%/500 mg.dL-1) than the intralipid sample (1.35%/500 mg.dL-1).  There is however, 
a potential problem in the non-invasive photoacoustic measurement which lies in the 
confounding effects of temperature change. 
2.1.2 Fluorescence-based Glucose Sensor 
Fluorescence-based glucose measurement methods have involved fluorescence 
spectroscopy to measure fluorescence intensity, anisotropy, or lifetime change with 
glucose concentration change.  Based on different transduction mechanism and 
recognition elements for glucose, these approaches fall into five categories listed below:   
(i) The lectin ConA – dextran affinity system,  
(ii) GBP based glucose sensing system,  
(iii) Apo-glucose oxidase or glucokinase sensor,  
(iv) Boronic acid – based glucose sensing systems, and  
(v) Gold or silver nanoparticles, quantum-dot, PEBBLEs, and nanotube based 
glucose sensing systems.  
The lectin ConA-dextran affinity system is the most intensively studied system.  It 
is reviewed in section 2.3.  The brief review of the rest of these techniques in the 
following section will focus on answering three questions:  (i) what is the basic 
mechanism of these fluorescent sensing methods? (ii) are the fluorescent decay 
mechanisms investigated and if so, how are the fluorescent lifetime changes related to 
glucose concentration change?  And finally, (iii) what are the measurement methods and 
choice of wavelengths?  
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2.1.2.1 GBP based Glucose Sensing System  
A variety of well characterized GBPs have been isolated from Escherichia coli 
and other bacteria.  The proteins have been engineered such that glucose binding events 
could be traced by site specifically attached fluorophores, either through conformational 
change-induced FRET between donor-acceptor pairs on the protein or by fluorescent 
changes from an environmentally sensitive single fluorophore (76,77).  Tolosa et al. 
demonstrated a mutated GBP with a single cysteine residue and an environmentally 
sensitive fluorophore 2-(4-iodoacetamidoanilino)naphthalene-6-sulfonic acid (I-ANS) 
(77).  In the experiments, the excitation wavelength was 325 nm and emission 
wavelength was 450 nm.  The response to glucose displayed a twofold decrease in 
intensity but no change in fluorescence lifetime.  Ye and Schultz fused two fluorescent 
reporter proteins (green fluorescent protein (GFP) as the FRET donor and yellow 
fluorescent protein (YFP) as the FRET acceptor) to each end of a GBP (76).  Glucose 
binding resulted in a conformation change and reduced FRET.  Both GBP systems have 
narrow glucose sensing ranges (up to 0.18 mg/dL) and the measurement wavelength is in 
the UV range (<400 nm) where tissue penetration of light is minimal.  All of these results 
were obtained from measuring intensity in free solutions.  Another recent study using 
GBP and surface plasmon resonance (SPR) has reported a the low sensing range of 
glucose concentration (up to 36 mg/dL) (78). 
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2.1.2.2 Apo-glucose Oxidase and Glucokinase Sensors 
An inactivated form of GOX has been developed without the ability to oxidize 
glucose wile maintaining the ability to bind glucose (79).  In the study carried out by 
D’Auria et al., the fluorophore, 8-anilino-1-naphthalene sulfonic acid (ANS) was non-
covalently bound to the apo-glucose oxidase (80,81).  The addition of glucose (from 0 to 
60 mM) caused ∼ 25% decrease in fluorescence intensity from ANS and a 25% decrease 
in lifetime as found using FD lifetime measurements in free solution (80).  In this 
research, the excitation wavelength was 335 nm while the emission wavelength was 535 
nm.  The same research group also explored using thermostable glucokinase from the 
thermophilic microorganism Bacillus stearothermophilus (BSGK) (82).  The ANS-
labeled glucokinase displayed about a 25% decrease in the emission intensity but no 
change in lifetime. The excitation wavelength in their study was 295 nm.  The McShane 
group used apo-glucose oxidase conjugated with TRITC and FITC-dextran to develop a 
competitive binding assay (83).  The competitive binding system was encapsulated into 
polyelectrolyte microspheres (~5 µm in diameter).  The sensitive study showed 67% 
change in fluorescence intensity signal as the glucose concentration ranged between 0 to 
720 mg/dL (55,84).  The toxicity and the stability of this apo-glucose oxidase sensor have 
not yet been reported. 
2.1.2.3 Boronic Acid-based Glucose Sensors 
Boronic acid binds covalently to diols to form five- or six-membered cyclic esters 
in aqueous basic media (85).  James et al. first synthesized derivatives of boronic acid 
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which were linked to a fluorophore which coupled molecular recognition of glucose to a 
fluorescence change (86-88).  They introduced the photoinduced electron transfer (PET) 
as a tool for the transduction of the fluorescence signal.  PET glucose sensors generally 
consist of a fluorophore and a boric acid receptor linked by a short spacer. In the absence 
of glucose, the fluorescence intensity of the anthracene fluorophore (EX/EM = 370/423 
nm) was quenched by the nitrogen atom within the PET sensor.  Upon binding of glucose 
to the boronic acid receptor, PET was suppressed, resulting in the recovery of the 
fluorescence intensity of anthracene.  The glucose sensing range was from 0.03 mM to 1 
mM in a 33% MeOH/H2O solution (pH=7.7).  Camara et al. developed a boronic acid 
receptor by combining another fluorophore pyranine with a boronic acid substituted with 
benzyl viologen as a quencher (89).  In the absence of glucose, the fluorophore/quencher 
complex is nonfluorescent.  Upon binding of glucose, the complex dissociates, resulting 
in increased fluorescence intensity.  DiCesare and Lakowicz  have also studied 
fluorescence lifetime changes with glucose binding to boronic acid derivatives, including 
an anthracene derivative which showed an increase in mean lifetime from 6.4 ns to 11.5 
ns with the addition of 10 mM glucose (90,91).  In their recent study, the Lakowicz group 
developed glucose sensing contact lenses by embedding several boronic acid containing 
fluorophores (92).  The approach may be suitable for continuous monitoring of tear 
glucose levels in the range of 0.05-1 mM.   However, glucose measurement using boronic 
acid is subject to several difficulties (85):  (i) many boronic acid-based sensors are not 
water-soluble; (ii) the selectivity for glucose among similar compounds (such as fructose, 
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galactose and mannose) is comparably lower than ConA-dextran affinity glucose sensor;  
and (iii) the sensitivity of the boronic acid-based sensors is influenced strongly by pH.  
2.1.2.4 Nanoparticle or Nanotube-based Glucose Sensors 
Aslan et al. reported using ConA-aggregated dextran-coated gold colloids and 
dextran with boronic acid-capped silver colloids to measure glucose concentration 
(16,93).  They measured the change of SPR by changing the size of the nanostructure 
geometry due to the competitive binding between glucose and dextran to ConA or 
boronic acid.   
Quantum dots (QDs) have been used in maltose sensing by Clapp et al (94,95), 
but have not yet been investigated for glucose sensing.  In the maltose-sensing research, 
maltose-binding proteins labeled with Cy3 as the FRET acceptor were immobilized on a 
CdSe-ZnS core-shell QD.  Change of QD lifetime owing to change of the immobilized 
maltose binding protein was measured using time-domain methods as discussed in 
section 3.2.  The advantage of using quantum dots may rely on the size-dependent 
absorption and high photostability.   
Barone et al. loaded Fe(CN)63-/GOX-suspended carbon nanotubes into a 200 µm 
× 1 cm (MWCO =13 kDa) microdialysis capillary tube (96).  The carbon nanotubes were 
tuned to have near-infrared (NIR) fluorescence emission.  Upon placing the capillary 
beneath human epidermal tissue samples, they measured the fluorescence intensity 
change of carbon nanotubes with glucose concentration change at an excitation 
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wavelength of 785 nm.  However, the detection limit of this sensing system was shown to 
be 34.7 µM.   
Xu et al.  presented an innovative polyacrylamide (PAA) PEBBLE glucose 
sensors (Probes Encapsulated by Biologically Localized Embedding) using ratiometric 
measurements (97).  Using an emulsion polymerization process, the PEBBLE 
nanoparticles (~45 nm in diameter) incorporated GOX, an oxygen-sensitive fluorophore, 
(Ru[dpp(SO3Na)2]3)Cl2,  and a reference dye, Oregon Green 488-dextran or Texas Red-
dextran.  The oxygen sensitive ruthenium dye was used to detect oxygen concentration 
change from an enzymatic reaction.  The PAA hydrogel eliminated the interferences such 
as protein binding or membrane/organelle sequestration.  The hydrogel matrix also 
minimized the dye toxicity to cells (98).  The glucose sensing range of this sensor is up to 
8 mM for fluorescence intensity measurement in PBS buffer solution (pH =7.2).  This 
method has a response time of 100 s and has only been tested with in vitro microscopy 
studies, thus the feasibility of using this sensor for in vivo sensing is not known.  The 
excitation wavelength in their study was 488 nm. 
As discussed in this section, while glucose sensing based on intensity change has 
been studied in some depth, the potential of fluorescence lifetime measurements has yet 
to be investigated in any detail (10).  Given that lifetime measurements have intrinsic 
advantages for in vivo sensing such as freedom from artifacts due to (i) light scattering, (ii) 
fluorophore concentration, and (iii) photobleaching, this research will explore frequency-
domain technique by measuring FRET effects change in the ConA-dextran affinity sensor. 
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2.2 Review of FRET Theory and FRET Application in Glucose Sensing 
2.2.1 Simplified FRET Theory 
The theory of FRET is quite complicated; therefore the section focuses on a 
comprehensive description of (i) FRET basic theory, (ii) FRET decay kinetics, and (iii) 
FRET decay kinetics measurements.  FRET is a physical process in which part of the 
energy from an excited fluorescent donor (D) molecule, nonradiatively transfers to 
another closely positioned molecule, defined as acceptor (A) located within 3-10 nm 
distance of the donor (26). The acceptor is not necessarily fluorescent (26).  In this 
nonradiative energy transfer process, the donor does not emit a photon and acceptor does 
not re-absorb a photon from donor.  Figure 2.2 illustrates the diagram of FRET and the 
Jabłoński diagram.  the following schematic equation describes the FRET process (99): 
D + hνE →  excited D + A Tk⎯⎯→ D + excited A   (2.4) 
 
where νE is the frequency of excitation; h is the Planck constant (6.626×10-34 J·s); and kT 
is the energy transfer rate.  The essential requirements for FRET to occur are: (i) adequate 
overlap in the emission spectrum of D and the absorption spectrum A; (ii) sufficiently 
high the quantum yield of D; (iii) a non-perpendicular relative orientation of the D-A 
transition dipoles (26); and (iv) the distance between D and A molecules should between 
~10 Å and ~100 Å. 
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Figure 2.2. Illustration of the process of FRET (upper figure) and Jabłoński diagram 
(lower figure) illustrates the FRET process.  D is the donor molecule and A is the 
acceptor molecule. r is the distance between donor and acceptor molecules. The 
parameters κr, κnr and κT correspond to the radiative relaxation, non-radiative relaxation, 
and fluorescence resonance energy transfer rate.  S0 is the electronic ground state and S1 
is the first excited singlet state.  A0 and A1 correspond to the ground and excited 
electronic state of the acceptor, respectively. 
 
 
If the donor and acceptor are assumed to be separated a constant distance (r), then with 
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where 0τ  is the unquenched donor fluorescence lifetime, and 0R is the Förster distance. 
The Förster distance is defined as (92): 
       
2
6 4
0 5 4 0
161.9 ( ) ( )D A
A
QR F d
n N
κ λ ε λ λ λπ
∞= ∫             (2.6) 
 
where Q is the donor quantum yield in the absence of acceptor;  n is the refractive index 
of solvent, for water, n is 1.33; ( )DF λ is the normalized fluorescence spectra of the donor; 
( )Aε λ  is the extinction coefficient of the acceptor;  NA is Avogadro’s number 
(6.0221415×1023); and 2κ  is the orientation factor.   The integral in Equation 2.6 is 
defined as the overlap integral J(λ) and it can be calculated from the overlap of the donor 
emission spectra and acceptor absorption spectra as well as from PhotochemCAD 
software (100) . 
( ) ( ) ( ) 4
0 D A
J F dλ λ ε λ λ λ∞= ∫      (2.7) 
 
The overlap integral J(λ) indicates the degree of spectral overlap between the 
donor emission and acceptor absorption.  Figure 2.3 illustrates the spectra overlap of one 
FRET pair studied in this research.  The acceptor, QSY21 is a non-fluorescent quencher 
while the donor is AF647. Both were obtained from Molecular Probes (Eugene, OR).  It 
has to be emphasized that the spectral overlap is a necessary, but not a sufficient 
condition for FRET to be happen.  
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Figure 2.3. The absorption spectra of QSY21 (the dashed line) and the emission spectra 
of AF647 (the solid line) in PBS buffer (pH= 7.2).  The shadow area in the figure shows 
the spectral overlap between donor (AF647) emission and acceptor (QSY21) absorption.  
The acceptor molecule, QSY21 is a non-fluorescent quencher. 
 
 
Upon substituting Equation 2.7 into 2.6, and express the wavelength in 
nanometers, the Förster distance in Å is given can be written: 
( ){ }6 5 2 40 8.79 10R n QJκ λ− −= ×      (2.8) 
The orientation factor 2κ  is equal to: 
 ( )( ) ( )2 22 3 cos 3cos cosA D D A T D AR Rκ µ µ µ µ θ θ θ= − = −uuruur uurur uurur         (2.9) 
where the 
Aµ
uur  and Dµ
uur  are the unit vectors of the acceptor and donor transition moments 
and R
ur
 is the unit vector joining the donor and the acceptor.  θΤ is the angle between the 
emission dipole of the donor and the absorption dipole of the acceptor.  θD and θΑ are the 
angles between these dipoles and the vector R
ur
 (26).  The value of 2κ  can vary from 0 to 
4, but the orientation factor is rather difficult to determine in experimental systems.  It is 
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normally assumed that 2κ  equals to 2/3 for randomly oriented D and A in bulk solutions 
(26).  However, for immobilized systems, the orientation factor must be determined using 
Equation 2.9.  Obtaining exact 2κ  is difficult and it has been suggested that the resulting 
uncertainty in 2κ  contributes a ~10% error in the Förster distance (101). 
As shown in Equations 2.5-2.9, if the overlap integral J(λ); the orientation factor 
2κ ; the donor quantum yield Q; the distance between donor and acceptor r; and the 
donor unquenched lifetime are known, then we may calculate the Förster distance 
0R  and 
the energy transfer rate kT.   
The observed donor lifetime, τF, decreases with increasing energy transfer rate as 
shown in the follow equation:  
0
6
0
1
1
F
nr r T R
r
ττ κ κ κ= =+ + ⎛ ⎞+ ⎜ ⎟⎝ ⎠
              (2.10) 
The FRET efficiency, E is defined as the ratio of energy transfer rate kT to the 
total decay rate of the donor and can be computed as follows: 
( ) 6
0
0
1
1
1
T T
nr r T T
E r
r
R
κ κ
κ κ κ κτ
= = =+ + + ⎛ ⎞ +⎜ ⎟⎝ ⎠
           (2.11) 
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The FRET efficiency is the fraction of energy absorbed by D that is 
nonradiatively transferred to the A. Therefore E could be used as the indicator of 
“strength of FRET.”  Equations 2.10–2.11 are valid only when the distance, r between D 
and A is constant.  Both equations show that τF and E are strongly dependent on the 
distance between D and A.  Figure 2.4 illustrates the simulation results of FRET 
efficiency as a function of D-A distance at different Förster distances and shows how the 
FRET efficiency is influenced by the change in the D-A distance.  For example, if the 
Förster distance is 40 Å, the FRET efficiency approaches zero when the D-A distance is 
90 Å.  When the D-A distance is less than 20 Å, the FRET efficiency approaches 100% 
and will not change by further reducing the D-A distance.  The observed FRET efficiency 
dependence on the D-A distance embodies the principle of FRET optical sensing 
techniques.  The unique feature of FRET technique is its capability to quantitatively 
measure molecular interaction within 10-100 Å distance (101) . In a well studied 
allphycocyanin (APC, as D)-ConA and malachite green (MG, as A)-dextran affinity 
system, the computed D-A distance distribution curve had two maxima at 45 Å and 75 Å 
(102).  With changing glucose concentrations, the calculated D-A distances also change 
significantly. 
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Figure 2.4. Dependence of FRET efficiency on the distance between D and A.  The 
legend in the figure shows the different Förster distances, 0R , in nanometers.  All the 
curves in this figure are the simulation results from Equation 2.11.   
 
 
 
2.2.2 Summary of FRET Application in Glucose Sensing 
FRET has been widely used to investigate: (i) protein structure, protein folding, 
and protein interactions (103); (ii) carbohydrate structure and conformation (104); (iii) 
metal ions sensing (Zn2+, Cu2+) (34);  (iv) enzyme activity and kinetics (26); (v) nucleic 
acid structure and interaction (105); (vi) molecular interactions in membranes;  and (vii) 
affinity sensors for quantitatively detecting gene, antigen, protein, and glucose 
concentration (106).   This section focuses on reviewing the application of FRET 
specifically for glucose sensing.  Table 2.2 provides a cumulative summary of the 
literature using FRET to measure glucose concentration in vitro.   
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Table 2.2. Review of literature involving glucose sensing based on FRET competitive-binding affinity system*. 
Reference Donor/ Acceptor FRET affinity system R0 (Å) λ, EX/ EM 
Measurement 
methods/instru
mentation 
Glucose 
sensing range Comments 
Meadows 
and 
Schultz 
(1988) 
(107) 
FITC/rhodamine 
donor-dextran 
(MW=70,000)/ 
acceptor-ConA 
N/A 470 /520 nm fluorescence intensity change 
up to 200 
mg/dL 
demonstrated glucose 
sensing based on the level 
of FITC fluorescence in a 
homogeneous solution 
Meadows 
and 
Schultz 
(1993) 
(108) 
FITC/TRITC 
donor- dextran 
(MW=70,000)/ 
acceptor-
succinylated-
ConA 
N/A 480 /540 nm fluorescence intensity change 
detection limit 
was 0.05 µg/ml 
and glucose 
concentration 
up to 1600 
mg/dl, response 
time was 10 
mins 
demonstrated reduction of  
aggregation and improved 
sensitivity of FRET 
system over previous 
study 
Lakowicz 
and 
Maliwal 
(1993) 
(54) 
AMCA or CB or 
FITC/Texas Red 
or TRITC/MG 
donor-ConA or 
donor-
succinylated-
ConA /acceptor-
mannoside or 
acceptor-
dextran 
(MW=10,000) 
40~65 
360/435 nm, 
AMCA-ConA 
360/430 nm, 
CB-ConA) 
442nm , FITC-
ConA 
570 or 576 nm, 
Texas Red-
ConA 
frequency-
domain 
(modulation 
frequency from 
10 to 500 MHz) 
up to 4500 
mg/dL 
demonstrated the use of 
phase-modulation 
measurements for glucose 
assays using a variety of  
FRET pair 
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Table 2.2 Continued. 
Reference Donor/ Acceptor 
FRET affinity 
system 
R0 
(Å) λ, EX/ EM 
Measurement 
methods/instru
mentation 
Glucose 
sensing range Comments 
Lakowicz 
and 
Szmacinski 
(1993) (32) 
AMCA/TRITC 
donor-ConA 
/acceptor-
mannoside 
42 360 nm / ~450 nm 
frequency-
domain at 200 
MHz 
up to 4500 
mg/dL 
qualitatively 
demonstrated the ability 
to perform lifetime 
measurements for glucose 
sensing 
Tolosa et al. 
(1997) 
(109) 
Ruthenium 
MLC/MG 
donor-ConA 
/acceptor-
insulin-maltose 
42 488/633±40 nm 
frequency-
domain 
(modulation 
frequency from 
10-1000 KHz) 
up to 1800 
mg/dL. 
demonstrated the use of 
long lifetime dyes 
(average ~500ns to 
enable blue LED as light 
source 
Tolosa et al. 
(1997) (51) Cy5/MG 
donor- 
ConA/maltose-
Insulin-acceptor 
35 580/620 nm time-domain up to 1800 mg/dL 
demonstrated the use of 
longer wavelength dyes 
and red laser diodes 
Ballerstadt 
and Schultz 
(1997) (52) 
FITC/RITC 
donor- dextran 
(MW=2,000k) 
and acceptor-
Dextran 
N/A 495/ 520 nm fluorescence intensity change 
up to 300 
mg/mL 
demonstrated a new 
sandwich-like affinity 
assay based on the use of  
two groups of polymers 
which consisted of the 
same type of affinity 
ligands but different 
indicator tags 
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Table 2.2 Continued. 
Reference Donor/ Acceptor FRET affinity system R0 (Å) λ, EX/EM 
Measurement 
methods/instru
mentation 
Glucose 
sensing range Comments 
Russell et 
al. (1999) 
(40) 
FITC/TRITC 
donor- dextran 
(MW2, 000k)/ 
acceptor-ConA  
two dyes 
immobilized 
into 
Poly(ethylene 
glycol) hydrogel 
microspheres 
N/A 488/500-660 nm 
fluorescence 
intensity change 
up to 600 
mg/dL 
demonstrated 
immobilization of FRET 
pair into PEG hydrogel 
Rolinski et 
al. (2000, 
2001,2004
) 
(50,110,11
1) 
APC/MG 
donor-ConA/ 
acceptor-dextran 
(MW=70,000) 
59.3 670/>715 nm time-domain up to 540 mg/dL 
demonstrated a long 
wavelength FRET system 
using time-domain 
measurements.  the 
distribution function was 
used to determine glucose 
concentrations 
McCartne
y et al. 
(2001) 
(53) 
APC/MG 
donor-ConA / 
acceptor-dextran 
(MW=70,000) 
59.3 650/>695 nm time-domain 45-540 mg/dL 
investigated performance 
in serum and interference 
by albumin 
D’Auria et 
al. (2002) 
(82) 
Tryptophan/o-
nitrophen-β-D-
glucopyranoside 
Bacillus 
Stearothermophi
lus / o-
Nitrophen-β-D-
glucopyranoside 
(acceptor) 
N/A 290/340 nm anistropy measurement 
up to 108 
mg/dL 
demonstrated the use of  a 
thermostabe glucokinase 
and use of anisotropy 
measurement 
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Table 2.2 Continued. 
Reference Donor/ Acceptor FRET affinity system R0 (Å) λ, EX/EM 
Measurement 
methods/instru
mentation 
Glucose 
sensing range Comments 
Arimouri 
et al. 
(2002) 
(112) 
Phenanthrene/pyr
ene 
donor-boronic 
acid-acceptor N/A 
299 or 342 
nm/397 or  417 
nm 
fluorescence 
intensity change N/A 
demonstrated the use of a 
modular design approach 
to build an intramolecular 
energy transfer glucose 
sensor.  The preliminary 
experiments were carried 
out in a basic solution 
(pH=8.2), glucose 
sensing range was not 
shown 
Ye and 
Schultz 
(2003) 
(76) 
GFP/YFP 
donor-glucose 
binding protein 
(from E. coli)-
acceptor 
N/A 395/527 nm fluorescence intensity 
10% change 
over 0-0.18 
mg/dL; 
response time 
less than 100s 
demonstrated the use of a 
novel genetically 
engineered glucose 
indicator protein 
Ballerstadt 
et al. 
(2004) 
(113) 
AF647/QSY21 
donor- dextran 
(MW 70,000) / 
acceptor- ConA-
Sepharose 
80 645/675 nm ratiometric measurement 
13% change 
over 45-270 
mg/dL 
demonstrated the use of a 
long wavelength dye and 
immobilized ConA within 
Sepharose beads 
Chinnayel
ka and 
McShane 
(2004) 
(55) 
FITC/TRITC 
donor-
dextran/accepor-
ConA 
55 488/ 560 nm fluorescence intensity 
27% change 
over 0-1800 
mg/dL 
demonstrated the use of 
layer-by-layser self 
assembly of dextran and 
ConA into polymer 
microparticles 
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Table 2.2 Continued. 
Reference Donor/ Acceptor FRET affinity system R0 (Å) λ, EX/EM 
Measurement 
methods/instru
mentation 
Glucose 
sensing range Comments 
Chinnayel
ka and 
McShane 
(2005) 
(83) 
FITC/TRITC 
donor-dextran/ 
acceptor- apo-
glucose oxidase 
N/A 480/ 500-625 nm 
fluorescence 
intensity 
67% change 
over 0-720 
mg/dL 
demonstrated the use of 
apo-glucose oxidase and 
polymer microcapsule 
Ibey et 
al.(2005) 
(114) 
AF594/AF647 
donor-
glycodendrimer/
acceptor-ConA 
N/A 610/ 610-835 nm 
fluorescence 
intensity 
67% change 
over 0-600 
mg/dL 
demonstrated the 
feasibility of using a 
glycodendrimer to 
replace dextran in the 
competitive binding 
system 
Liang et 
al. (2005) 
(57) 
AF568/AF647 
donor-
dextran/accepto
r-ConA 
82 568/600 nm Frequency-domain 
67% change 
over 0-
224mg/dL 
demonstrated that 
frequency-domain 
measurement can be used 
to extract FRET decay 
kinetics 
Blagoi et 
al. 
(2005)(46) 
FITC/Texas Red 
donor-ConA-
polystyrene 
particles/accept
or-dextran 
N/A 470/490-700nm 
Fluorescence 
intensity N/A 
demonstrated the use of 
polystyrene particles 
labeling with FITC-ConA 
for screen carbohydrates 
Chinnayel
ka and 
McShane 
(2006)(11
5) 
Cy5/TRITC 
donor-apo-
GOX/acceptor-
dextran 
N/A 543/560-725 nm 
Fluorescence 
intensity 0-720 mg/dL 
demonstrated the use of a 
long-wavelength Cy5 dye 
replacing previous FITC 
dyes 
* part of the table is reproduced from Liang et al.(57)  
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2.3 ConA-dextran FRET Affinity Sensor 
2.3.1 Properties of ConA and Dextran 
At physiological pH, 7.4, ConA is a tetramer of four identical subunits.  ConA 
exists as a dimer at low pH, <5.5.  Each subunit (MW= 26,000) has 237 amino acid 
residues and one sugar binding site specific to glucose-, mannose-, and fructose-like 
saccharides.  The cross section of each subunit in ConA is about 40×39 Å in cross 
section and each subunit is 42 Å high (116).  The tetramer (MW= 104,000) has four 
independent sugar binding sites.  The binding clefts are located 65 Å apart (117).   
Excess Mn2+, Ca2+ (1mM) is necessary for the sugar binding ability of ConA.  Table 2.3 
lists the specificity of ConA to different sugar molecules.  Although maltose and 
fructose have higher binding affinities than glucose, only glucose is presenting a 
significant amount in blood plasma and interstitial fluid (70-140mg/dL (118) ).  
 
 
Table 2.3. Association constants of  some sugar molecules to ConA (49) 
Sugar Kb (L/mol) 
Maltose* 2880 
Fructose* 1370 
Glucose# 400 
Sucrose* 526 
Dextran# 15000 
* at pH=6.2, 2˚C 
# at pH=7.2, 27˚C 
b [ ]
[ ][ ]
ConA sugarK
ConA sugar
−=  
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Succinylated ConA (Succinyl-ConA) was also tested for glucose sensing studies 
(108).  By reacting lysine residues on ConA with succinic anhydride, the resultant, 
Succinyl-ConA exists as a dimer in neutral environment.  Changing from ConA to 
Succinyl-ConA did not show significant improvement in sensitivity and sensing range of 
glucose sensing (108,119). 
There may be a toxicity concern when using ConA within in vivo implantable 
sensors because it has been found that ConA is a T-cell mitrogen (120).  The lethal dose 
of ConA in 50% of tested animals is 41.5 mg/kg delivered intraperitoneally and 50 
mg/kg delivered intravenously.  In the study by Ballerstadt et al. (44), the amount of 
ConA in the implantable sensors was less than 0.12 µg/kg of body weight.   For the 
ConA-dextran system used in this study in a 1 cm3 implantable cubic phantom, the 
concentration was less than 12 µg/kg of body weight.  It is reasonable to expect that the 
ConA-dextran system, once implanted, will pose a minimal risk to the diabetic patients, 
especially since ConA will be immobilized and sequestered. 
Dextran is a long-chain polysaccharide with many external branches.  Dextran 
molecular weight ranges from 3000 Da to 5,000,000 Da.  Dextran is a biocompatible and 
biodegradable polymer that is widely used in surgery and medicine (121).  The 
multivalent binding between dextran and ConA are still not fully understood even 
though some published work exists to explain this receptor-ligand interaction (122). 
2.3.2 ConA-dextran Affinity System 
The principle of the ConA-dextran affinity sensor is the competitive and 
reversible binding of ConA to dextran and glucose in solution. 
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Figure 2.5 illustrates the FRET effects in ConA-dextran affinity system. The 
following reversible reaction takes place in the sensing system: 
1kConA glucose ConA- glucose⎯⎯→+ ←⎯⎯     (2.12) 
                     (receptor)   (analyte) 
2kConA dextran ConA dextran⎯⎯→+ −←⎯⎯    (2.13) 
                    (receptor)   (multivalent ligand) 
 
 
 
Figure 2.5. ConA-dextran affinity sensing system in presence of glucose in solution. 
 
 
 
The first use of ConA-dextran affinity system to monitor glucose concentration 
was pioneered by Schultz et al.(48) As shown in Table 2.2, followed research by other 
groups focused on how to improve the sensitivity, stability, reversibility, and sensing 
ranging, of the system in several different ways such as: (i) changing the donor-acceptor 
FRET pairs (32,109); (ii) replacing the dextran with other sugar molecule or dendrimers 
(51,114); (iii) introducing microspheres into the system as “hosts” for the protein ConA 
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and dextran (40,41); (iv) applying time-resolved measurements instead of intensity 
measurements (50,54); and (v) carrying out in vivo measurements using implantable 
microspheres (41).  This research focused on analysis of the FRET decay kinetics within 
the affinity system using FD measurements.  Presented next are methodologies for 
fluorescence decay kinetics and light propagation in scattering media as a prelude to the 
results.  
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3. METHODS: FLUORESCENCE DECAY KINETICS, LIGHT 
PROPAGATION IN FDPM 
3.1 Fluorescence Decay Kinetics with and without FRET Process 
3.1.1 Fluorescence Decay Kinetics without FRET 
Fluorescence decay kinetics describes the general process of fluorescence 
emission when fluorophores return from the excited energy states to the ground energy 
states.  Table 3.1 provides an overview of fluorescence decay kinetics without FRET and 
shows that, different fluorophores follow different decay kinetics.  Two-exponential 
decay kinetics are widely employed in fluorescence sensing systems (123).  Our 
previous results showed that the average lifetime τavg, which could be easily extracted 
from experimental measurements, can be used to describe multi-exponential or 
stretched-exponential decay kinetics (123).  
3.1.2 FRET Decay Kinetics 
In a homogenous solution, the distance distribution of acceptors around a donor 
can be described as the probability function ρ(r), where ( )
0
R
r drρ∫  is the number of 
acceptor molecules in a spherical volume of radius R. 
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Table 3.1. Overview of fluorescence decay kinetics model without presence of FRET in 
non-scattering solution.  All the models are normalized to the incident intensity I0 at time 
zero. 
Decay 
kinetics Equation Comments 
Example/
reference 
Single-
exponential 
 the simplest 
decay kinetics 
model 
DTTCI 
(124) ICG 
Multiple-
exponential  
fluorophores 
resides in 
different 
environments 
aj is the pre-
exponential 
factor 
(26) 
Two-
exponential  
fluorophore 
molecules exist 
two different 
form in solution 
SNAFL 
SNARF 
(125) 
Stretched-
exponential  
fluorophore 
dyes are 
quenched by a 
non-fluorescent 
agent. α and β 
are functions of 
the diffusion 
coefficients of 
the fluorophore 
and quencher 
collagen 
elastin 
(126,127) 
Single-
stretched-
exponential 
 
potential 
fluorescence 
quenching of 
one fluorophore 
by another 
(123) 
( ) 0tsigI t e τ−=
( ) 1 21 2t ttwoI t a e a eτ τ− −= +
0.5( )( ) t tstI t e
α β− −=
0.5
single-st 1 1 2( ) exp( / ) exp( )I t a t a t tτ α β= − + − −
1
/
( )
n
j
mult j
j
t
I t a e
τ
=
−= ∑
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If the donor fluorophore has a single lifetime, τ0, and it follows the single-
exponential decay, then in the presence of acceptors, the donor fluorescence, I(t), in 
response to an incident excitation pulse I0 at time zero, can be described as follows:  
                     (3.1) 
 
where kT(r) is the distance-dependent energy transfer rate as defined in Equation 2.5.  
Combining Equation 2.5 with the above equation, the donor fluorescence can be written 
as follows: 
          dr
r
RtexprtexptI o
oo
⎟⎟⎠
⎞
⎜⎜⎝
⎛
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⎞
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⎞⎜⎝
⎛⎟⎟⎠
⎞
⎜⎜⎝
⎛−−−−= ∫
∞
0
6
(1)()( τρτ                (3.2) 
To date, most FRET studies for sensing and imaging still estimate a single D-A 
distance and assume ρ(r) is equal to unity (128).   Only a few studies have provided 
analytical evaluation of ρ(r) (34).  For a random, homogenous, three-dimensional 
distribution of acceptors (no diffusion and very low donor concentration), the well-
known Förster model predicts the time-dependent donor fluorescence, I(t) (26): 
1/ 2
0 0( ) / ( / )I t exp t tτ γ τ⎡ ⎤= − −⎣ ⎦      (3.3) 
where ACA /][=γ , [A] is the acceptor concentration and CA is the critical acceptor 
concentration, ( )2 3 303 2A AC N Rπ= .   
 When the energy transfer between two donors is considered, the Huber’s model 
modified the expression of  time-dependent donor fluorescence (129): 
1
2
0 0( ) / ( / 2 )( / )DI t exp t tτ γ γ τ⎡ ⎤= − − +⎣ ⎦     (3.4) 
[ ]}{( )0 0( ) / ( ) 1 ( )TI t exp t dr r exp tk rτ ρ∞= − − − −∫
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where  3
00.135 ( )
DD
D AC N R= , [D] is the acceptor concentration, and CD is the critical donor 
concentration,  [ ] /D DD Cγ = .  R0DD is the critical energy transfer distance for donor-donor 
energy transfer. 
Gosele and Hausers’ model considered the diffusion of donor and acceptor 
molecules in solution and resulting in the following expressions for time-dependent 
donor fluorescence (130): 
 (3.5) 
  (3.6) 
where D is the sum of diffusion coefficients of the acceptor and donor molecules; *r  is 
the interaction radius; and rAD is the collision distance. 
 In solid and liquid media where the donor and acceptors are embedded in 
restricted geometries, Klafter and Blumen proposed a 3D fractal FRET decay model 
(131): 
1
2
0 0( ) / ( / )I t exp t B tτ τ⎡ ⎤= − −⎣ ⎦     (3.7) 
where B is a time-dependent factor.  All these derived models can be summarized as a 
generalized Förster model as shown in Table 3.2: 
1 1( ) 2I t exp t t
β
γα α
⎡ ⎤⎛ ⎞= − −⎢ ⎥⎜ ⎟⎝ ⎠⎢ ⎥⎣ ⎦
     (3.8) 
where α (ns) is the unquenched lifetime of the donor, and the parameter β is related to 
dimensionality of the affinity system (1/2 for three dimensional and 1/3 for two 
dimensional systems). 
1
2*
0 0( ) / 4 [ ] ( / )AI t exp t D r A N t tτ π γ τ⎡ ⎤= − − −⎣ ⎦ * D Ar r>
1
22
0( ) / 4 [ ] 8 [ ] ( )D A A D A AI t exp t D r A N t r A N D tτ π π⎡ ⎤= − − −⎣ ⎦ * D Ar r<
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Table 3.2. Summary of FRET decay kinetics models in homogenous, non-scattering 
medium. 
FRET 
decay 
model 
Description α 2γ β 
Förster 
(26) 
3D, no diffusion, 
homogeneous τ0 γ 1/2 or 1/3 
Huber 
(129) 
Donor-donor 
energy transfer was 
also considered 
τ0  1/2 
Gösele 
(130) 
Added donor-
acceptor diffusion 
influence 
τ0 
 
N/A 
 
N/A 
1/2 
 
1/2 
Blumen 
and 
Klafter 
(131) 
Solid or liquid, 
condensed media τ0 B 1/2 
 
 
Rolinski et al. recently pioneered an approach to invert Equation 3.1 in order to 
determine the D-A distance distribution function (102,110,111,132).  They transformed 
Equation 3.1 into a Fredholm equation and solved for the D-A distribution subject to the 
constraint that the distance between the D-A pair cannot be less than that allowable by 
their molecular structures.  They expanded the unknown ρ(r) into a finite series (as 
shown in Equation 3.9) of orthonormal Laguerre polynomials and optimized the solution 
for the coefficient of the polynomial which provides the best fit to I(t) from time-domain 
measurements (133).  
( ) ( )10 0
0
0 0
s s
i i
i
r d
r
R a L r R r d
ρ ∞−
=
≤ ≤⎧⎪= ⎨ ≥⎪⎩ ∑
    (3.9) 
2
Dγ γ⎛ ⎞+⎜ ⎟⎝ ⎠
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where ( )0siL r R  is the infinite series of orthonormal Laguerro polynomials and sia are the 
coefficients.  The parameter d is the minimum donor-acceptor distance.   
Using time-domain measurements, Rolinski et al. showed that the distribution 
function can be used to monitor glucose concentration in a solution-based FRET system 
of APC and MG (134,135).  Recently they compared ρ(r) from APC-MG FRET system 
with rhodamine 123-MG FRET system (110).  The two systems have similar Förster 
distances but different molecule sizes and therefore should have different ρ(r).  However 
their simulated ρ(r) from time-domain experiments showed similar trends in both 
systems.  The discrepancy between simulation results and biophysical theory indicates 
more work should be done in the future to improve the inverse solution technique.  
3.2 Measurement of Fluorescence Decay Kinetics with or without FRET 
Fluorescence decay kinetics can be measured using one of three broad classes of 
measurements: (i) continuous wave (CW); (ii) time-domain measurements which 
involve a pulse of excitation light; or (iii) FD measurements which involve a modulated 
light.  The latter two measurements are shown in Figure 3.1 and consist of monitoring 
the time-response of the fluorescence emission.   
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Figure 3.1. Illustration of time-domain (upper figure) and FD (lower figure) to measure 
fluorescence decay kinetics with or without the presence of FRET. 
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In time-domain measurements, a pulse of excitation light contacts the sample and 
the pulse generating a fluorescence light which is recorded, and whose width indicates 
the distribution of activated states.  Typically the measurement of I(t) can be fit to one of 
a number of decay kinetics models as discussed above.  Difficulties with time-domain 
measurements involve: (i) a reduced signal to noise ratio (SNR) in the fluorescence 
detected; and (ii) long data acquisition time.  FD approaches represent a time-resolved 
measurement conducted in frequency-space.  Intensity modulated excitation light 
produces fluorescent light modulated at the same frequency as the incident excitation 
light, but phase-shifted and amplitude attenuated relative to the incident light.  Upon 
conducting measurements across a range of modulation frequencies (kHz – GHz), the 
same temporal information obtained from time-domain techniques can be achieved using 
FD or “phase-modulation” approaches.  The drawback to conventional phase modulation 
approaches is the need for a “reference” dye in order to accurately report the phase-delay 
independent of instrument responses (32).  The advantage of conducting time-dependent 
measurements, whether in time- or frequency-domains, is that they are independent of 
the amount of fluorophore present, thereby enabling an accurate sensing approach for 
fluorescence decay kinetics without the issue of fluorophore loading.  However, without 
proper analysis of time-dependent measurements, the presence of tissue-like scattering 
creates a photon “time-of-flight” which impacts the phase and amplitude of FD 
measurements as well as the breadth of the re-emitted fluorescence pulse in time-domain 
measurements.  Previous research in our group has demonstrated that the presence of 
scattering can be properly taken into account and eliminate the need for a “reference” 
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measurement using conventional phase modulation approaches (30,123).  In this 
research, we used FD measurement to analysis the FRET decay kinetics.  A more 
rigorous discussion of FD measurement is provided in section 3.3 
3.3 Decay Kinetics Analysis in Non-scattering and Scattering Solutions 
3.3.1 Decay Kinetics Analysis in Non-scattering Solutions 
Frequency-domain fluorescence lifetime measurement in non-scattering solution 
involves: (i) excitation of a fluorophore by a light source whose intensity is modulated at 
frequency ω, and (ii) detection of the resulting fluorescence light perpendicular to the 
incident light.  Figure 3.2 (a) illustrates the physical process of FD measurement of 
decay kinetics in dilute, non-scattering solution.  In dilute solution, the measured 
fluorescence phase shift (θ) and modulation ( ( )( )
( )
( )
ac AC
M
dc DC
ω ω
ω ω= ) relative to the source 
are functions of the fluorophore decay kinetics model.   Here are three situations: 
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(1) For fluorophores which follow single-exponential decay kinetics as shown in 
Table 3.1, the phase shift and modulation can be directly related with fluorophore 
lifetime as shown: 
( )M arctanθ ωτ=     (3.10) 
( )21 1
M
M ωτ= +                             (3.11) 
where ω is the modulation frequency (usually in MHz); τ  is the lifetime of the 
fluorophore (usually several nanoseconds).  In the experiment, the choice of modulation 
frequency is very important for choosing RF frequency synthesizer.  As shown in Figure 
3.3, for lifetime change from 1.0 to 0.5 ns (e.g. Cy5 dye), the useful frequency range can 
be from 30 MHz to 1000 MHz.  For lifetime change from 10 ns to 20 ns, the useful 
frequency range will be from 0 MHz to 100 MHz.   In my research, the fluorophore we 
used are (1) pH sensitive C-SNAFL-1 with lifetime 3.65 ns at pH = 7.0 (136); and (2) 
AF568 with lifetime 3.6 ns (57).   Therefore the suitable modulation frequency range is 
within 0-200 MHz. 
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Figure 3.2. Frequency-domain lifetime measurement in (a) non-scattering solution; and 
(b) scattering solution. Figure (c) illustrates the amplitude attenuation AC/ac, phase shift 
θ, and the mean intensity DC/dc. 
 
(a) 
(b) 
Fluorescence light
Excitation light 
Excitation light 
Fluorescence light  
(c) 
ac 
dc θ
DC
time 
AC 
Incident light 
Fluorescence light 
55 
 
 
 
Figure 3.3. Phase shift change (upper figure) as the function of modulation frequency at 
different fluorescence lifetimes. Modulation (lower figure) as the function of modulation 
frequency at different fluorophore lifetimes. The two figures come from simulation 
results of Equation 3.10 and 3.11. 
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(2) For fluorophore which follows multi- or stretched- exponential decay kinetics 
as shown in Table 3.1, the measured phase shift and modulation can related to the 
lifetime as shown in the following equations: 
( )
∫
∫
∞
∞
=
0
0
)(
)(
)(
dttI
dttsintI
N
ω
ω    (3.12) 
( )
∫
∫
∞
∞
=
0
0
)(
)(
)(
dttI
dttcostI
P
ω
ω    (3.13) 
 
( ) ( )( )M
N
arctan
P
ωθ ω ω
⎡ ⎤= ⎢ ⎥⎣ ⎦
   (3.14) 
( ) ( )2 2( ) ( )MM N Pω ω ω= +    (3.15) 
where N(ω) is the imaginary part of Fourier transform of the decay kinetics, I(t) and the 
P(ω) is the real part of the Fourier transform.  The phase-shift and modulation ratio can 
be related to those unknown parameters in decay kinetics models through N(ω) and P(ω).   
Those unknown parameters can be determined from the best fit between model predicted 
values (θp(ω) and Mp(ω)) and experimental measured (θM(ω) and MM(ω)) as indicated by 
χ2, 
( ) ( ) ( ) ( )2 22 1 M p M pM M
M
θ ω θ ω ω ωχ ν δθ δ
⎧ ⎫− −⎛ ⎞ ⎛ ⎞⎪ ⎪= +⎨ ⎬⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠⎪ ⎪⎩ ⎭
∑ ∑   (3.16) 
where δθ and δM are the estimated uncertainties in the phase shift and modulation results 
at each modulation frequency.  The value of χ2 is expected to be close to one for the 
57 
 
correct model, and depending upon the estimated δθ and δM (26).  In this research, the 
MatLab optimization toolbox (The Mathworks Inc., Natick, MA) was used to minimize 
χ2.   
(3) For fluorophores which follow FRET decay kinetics model, e.g. ConA-
dextran affinity glucose sensing system, a generalized Förster model shown in Equation 
3.8 is applied by taking a Fourier transform of Equation 3.8 as shown in Equation 3.17,  
                       ( ) ( ) ( )
0 0
1 12F I t exp i t dt exp t t i t dt
β
ω ω γ ωα α
∞ ∞ ⎡ ⎤⎛ ⎞= = − − +⎢ ⎥⎜ ⎟⎝ ⎠⎢ ⎥⎣ ⎦∫ ∫                       (3.17)  
The θ(ω) and M(ω) can be obtained from F(ω) as: 
( ) ( )( )P
IMAG F
arctan
REAL F
ωθ ω ω
⎧ ⎫⎡ ⎤⎪ ⎪⎣ ⎦= ⎨ ⎬⎡ ⎤⎪ ⎪⎣ ⎦⎩ ⎭
    (3.18) 
( ) [ ]( ) [ ]( )2 2( ) ( )pM IMAG F REAL Fω ω ω= +    (3.19) 
The parameters of α, β, and γ can be determined from the best fit between model 
predicted values (θp(ω) and Mp(ω)) and experimental values (θM(ω) and MM(ω) ) as 
indicated by χ2. 
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3.3.2 Decay Kinetics Analysis in Scattering Solution 
As illustrated in Figure 3.2 (b), fluorescence measurements in the presence of 
tissue-like scattering need to take into account: (i) the propagation of excitation light, (ii) 
the fluorescence lifetime of the dye, and (iii) the propagation of the fluorescence light 
emitted by the dye before being detected.  Therefore, the detected phase-shift and 
modulation (θM(ω) and MM(ω)) depend upon the medium optical properties (µs’ and µa) 
as well as the fluorescent decay kinetics.  Previously we successfully employed the 
diffusion approximation to the radiative transfer equation to predict the fluorescence 
photon density measured with FD techniques (30,58,123,124,136).  The details of the 
optical diffusion equation, the generated fluorescence photon density, and the 
relationships between the photon-density and the measurable quantities (θM and MM) 
have been discussed in the previous papers (30,124,137).  Below, a brief synopsis is 
provided. 
3.3.2.1 Optical Diffusion Equation and Generated Fluorescence Photon Density 
When light launches onto scattering solutions or tissue surface, the propagation 
of light is attenuated and scattered due to sample scattering and absorption.  When 
photons of excitation light activate the fluorophores inside the sample, the generated 
fluorescence light is again attenuated and scattered due to the scattering and absorption 
of the sample.  Figure 3.4 illustrates this physical process.   
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Figure 3.4. Illustration of fluorescence light propagation in scattering media. When 
scattered photons of the excitation light hit the fluorophores, the generated fluorescence 
light is again attenuated and scattered by the scattering media. 
 
 
The following two coupled optical diffusion equation can be used to describe for 
the propagation of fluorescence light for a homogenous scattering media: 
2 (r, ) (r, ) (r, )x x ax x x
iD U U Sωω µ ω ων∇
⎛ ⎞− + + =⎜ ⎟⎝ ⎠   (3.20) 
( ) ( ) ( )2 am ir, + µ + r, = r,m m m mD U U Sωω ω ων
⎛ ⎞− ∇ ⎜ ⎟⎝ ⎠   (3.21) 
Where the subscript x represents the excitation and the subscript m represents the 
emission.  Accordingly µax is the absorption coefficient at the excitation wavelength.  
µam is the absorption coefficient at the emission wavelength.  µaxf is the absorption 
coefficient owing to fluorophores at the excitation wavelength.  v is the speed of light in 
the solution, cv
n
= , n is the refractive index of the medium.  D is the diffusion coefficient 
which is related to the isotropic scattering coefficient µs’ and absorption coefficient µa, 
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through the relationship: ( ) 1,3 a sD µ µ −⎡ ⎤= +⎣ ⎦ .  The diffusion coefficients at the excitation 
and emission wavelength are denoted by Dx and the Dm respectively.  Sx(r,ω) is the 
excitation source term.  Sm(r,ω) is the emission source term due to the generation of 
fluorescent photons based on the excitation photon density Ux(r,ω) weighted by 
fluorescence decay kinetics.  Um(r,ω) is generated fluorescence photon-density.  The 
emission source in frequency domain for single, multi-, and stretched exponential decay 
kinetics and FRET exponential decay are: 
1( , ) ( , )
1m afx x m
S r v U r Q
i
ω µ ω ζωτ= −    (3.22) 
( , ) ( , )
1
j
m afx x m
j j
a
S r v U r Q
i
ω µ ω ζωτ
⎛ ⎞= ⎜ ⎟⎜ ⎟−⎝ ⎠∑    (3.23) 
exp
0
( , ) ( ) ( ) ( , )m afx st x mS r v I t exp iwt dt U r Qω µ ω ζ
∞
−
⎛ ⎞= ⎜ ⎟⎝ ⎠∫    (3.24) 
0
1 1( , ) 2 ( , )m afx x mS r v exp t t i t dt U r Q
β
ω µ γ ω ω ζα α
∞⎛ ⎞⎡ ⎤⎛ ⎞= − − +⎜ ⎟⎢ ⎥⎜ ⎟⎜ ⎟⎝ ⎠⎢ ⎥⎣ ⎦⎝ ⎠∫   (3.25) 
where mζ  is the detection efficiency factor of the system at the emission wavelength 
(which contains the system spectral response and the fluorophore spectral emission 
efficiency (30)). Q is the quantum efficiency of the fluorophore.  
Upon using Equations 3.22-3.25, the generated fluorescence photon-density 
Um(r,ω) can then be solved for single, multi- and stretched-exponential, and FRET decay 
kinetics in an infinite scattering medium: 
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where S(ω) is the source strength (in photons per second). i is a complex number 
( 1i = − ). The terms A and B are functions of optical properties (µsx’, µax, µsm’ and µam), 
v and ω (30,137). 
( ) ( ) ( ) ( )( ) 22
, ,
,
r r
A r
η ω ξ ζ ω ρ ωω ξ ρ ω
+= + ⎡ ⎤⎣ ⎦
    (3.30) 
( ) ( ) ( ) ( )( ) 22
, ,
,
r r
B r
ζ ω ξ η ω ρ ωω ξ ρ ω
−= + ⎡ ⎤⎣ ⎦
    (3.31) 
         ( ) ( ) ( ) ( ) ( ), x x m mr exp r cos r exp r cos rη ω β ω γ ω β ω γ ω= − − −⎡ ⎤ ⎡ ⎤ ⎡ ⎤ ⎡ ⎤⎣ ⎦ ⎣ ⎦ ⎣ ⎦ ⎣ ⎦   (3.32) 
( ) ( ) ( ) ( ) ( ), x x m mr exp r sin r exp r sin rζ ω β ω γ ω β ω γ ω= − − −⎡ ⎤ ⎡ ⎤ ⎡ ⎤ ⎡ ⎤⎣ ⎦ ⎣ ⎦ ⎣ ⎦ ⎣ ⎦   (3.33) 
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am ax
m xD D
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( ) ( )x m
x m
D D
D D
ωρ ω ν
−= −    (3.35) 
3.3.2.2 Relationships between Photon Density and Measurable Quantities (θM and mM) 
For fluorophores undergoing single-exponential decay kinetics, the relationship 
between fluorescence photon-density to the measured phase shift, θM, and modulation 
ratio MM, are shown in the following Equations 3.36 and 3.37.  For fluorophores 
undergoing multi-exponential, the measured phase shift, θM, and modulation ratio, MM, 
are shown in following Equation 3.38 and 3.39. 
 ( ), ,M single B Ar arctan A B
ωτθ ω ωτ
+⎡ ⎤= ⎢ ⎥−⎣ ⎦     (3.36) 
 ( ) ( ) ( )( )2 2, ,M single A B B Am r Aωτ ωτω − + +=    (3.37) 
( ) 2 2 2 2,
2 2 2 2
1 1
,
1 1
j j j
j jj j
M multi j j j
j jj j
a aB A
r arctan a aA B
ωτ
ω τ ω τθ ω ωτ
ω τ ω τ
⎛ ⎞+⎜ ⎟+ +⎜ ⎟= ⎜ ⎟−⎜ ⎟+ +⎝ ⎠
∑ ∑
∑ ∑    (3.38) 
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A
ωτ ωτ
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⎧ ⎫⎡ ⎤ ⎡ ⎤⎪ ⎪− + +⎨ ⎬⎢ ⎥ ⎢ ⎥+ + + +⎣ ⎦ ⎣ ⎦⎪ ⎪⎩ ⎭=
∑ ∑ ∑ ∑
 
(3.39) 
For fluorophores exhibiting stretched-exponential or FRET decay kinetics, 
numerical integration is needed to evaluate the integral in both equations 3.28 and 3.29.  
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The relationship between fluorescence photon-density to the measured phase shift θM 
and modulation ratio MM can be obtained by substitution of equations 3.28 and 3.29 into 
equations 3.18 and 3.19. 
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4. MEASUREMENTS OF FRET IN A GLUCOSE-SENSITIVE AFFINITY 
SYSTEM WITH FREQUENCY-DOMAIN LIFETIME SPECTROSCOPY∗ 
4.1 Introduction 
Most quantitative measurements of FRET optical glucose sensors utilize 
intensity-based methods (24,40,44,48,52).  Unfortunately, intensity measurements are 
functions of not only glucose concentration, but also of fluorophore concentration.  The 
measurement of intensity may also be influenced by photobleaching as well as 
instrumentation response function.  Furthermore, when used within tissues for in vivo 
sensing, the attenuation of intensity depends upon the varying optical properties of the 
tissue.  As a consequence, intensity-based measurements of FRET for a clinically 
relevant and implantable glucose sensor would require frequent in situ calibrations (24).  
As an alternative method, time-dependent measurement techniques offer an opportunity 
to assess FRET affects not simply from the amount of light collected, but from the 
temporal decay kinetics.  Both time- and frequency-domain fluorescence lifetime 
spectroscopy approaches enable direct time assessment of decay kinetics but both can 
also be impacted by photon “time-of-flight” in tissues.   
___________ 
∗ Part of this section is reproduced from “Measurements of FRET in a glucose-sensitive affinity system 
with frequency-domain lifetime spectroscopy,” by Feng Liang, Tianshu Pan, and Eva Sevick-Muraca, 
Photochemistry and Photobiology, 2005, 81, 1386-1394. with the permission of the American Society for 
Photobiology. 
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Previously, we and others have demonstrated the ability to measure simple decay 
kinetics using frequency-domain approaches to assess the lifetime of fluorophores in 
tissue-like scattering solutions (30,123,124,136,137) as well as of fluorophores 
immobilized within hydrogels (58).  The framework for extracting fluorophore decay 
kinetics from multiple scattered light is found in references (30,123,124,136,137).  Yet 
to date, there have been no reports to extend quantitative, time-dependent FRET sensing 
under conditions of tissue-like scattering.  There are, however, few reports in the 
literature which employ time-dependent techniques to monitor FRET of the ConA 
dextran affinity system in scatter-free solutions (50,53,132). 
In the first use of time dependent measurements for FRET sensing found in the 
literature, Lakowicz and Maliwal (54) employed frequency-domain measurement of 
phase-shift to infer FRET changes associated with glucose binding to ConA.  Using 
time-domain methods and a two-exponential decay model, Tolosa et al. (51) 
subsequently measured the average lifetime change in order to assess glucose 
concentration changes.  Using the red-shifted FRET pair system interrogated with time 
domain measurements, Rolinski and his coworkers (50,53,102,110,111,132,138) used a 
Förster-type equation in order to extract the changes in the distribution of donor-acceptor 
distances as a function of glucose concentration and as a direct measure of the 
competitive binding between ConA and dextran.   Their results represented the first use 
of time-dependent measurements to directly elucidate physical parameters which govern 
FRET decay kinetics. 
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In this work, we seek to apply FRET sensing using frequency-domain 
approaches in order to relate parameters from a Förster-type equation in a scatter-free 
medium for validation of the donor/acceptor ConA/dextran affinity system for 
characterization of competitive glucose binding prior to its immobilization for 
implantation in tissues.  To date, FRET decay kinetics of the ConA/dextran affinity 
system have not been quantitatively analyzed from frequency-domain measurements.  In 
the following, we first describe the affinity system, measurement approach, and decay 
kinetic analyses from frequency-domain measurements and then compare our results 
with those using time-domain measurements reported in the literature. 
4.2 Materials and Methods 
4.2.1 Donor-dextran/acceptor-ConA Affinity System. 
The protein, ConA, conjugated with AF647 at a labeling ratio of 2.8, was 
purchased from Molecular Probes (Eugene, OR).   MOPS (0.1 M, pH = 7.4) buffer 
consisting of 1mM Mn2+, Ca2+, and 2mM NaN3 was used to dissolve the acceptor-ConA 
conjugate as it has been shown that Mn2+ and Ca2+ need to be present in the ConA 
solution to maintain the saccharide binding properties (139).  The acceptor-ConA 
solution was then centrifuged to remove precipitates.  The final acceptor-ConA 
concentration was determined by subtracting the weight of precipitate from the total 
weight of ConA.  D-glucose (Sigma-Aldrich, St. Louis, MO) was dissolved into MOPS 
buffer solution at the concentration of 300 mg/mL and stored prior to experiments. 
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Amino dextran (MW 2 000 000; Helix Research Company, Springfield, OR) and 
AF568 carboxylic acid with succinimidyl ester (Molecular Probes, Eugene, OR) were 
conjugated following the Inman method (140).  Briefly, prior to incubation of dextran 
with AF568 succinimidyl ester, 10 mg amino dextran was dissolved in 0.4 mL sodium 
bicarbonate buffer (pH = 8.3) and then vortexed continuously for 5 mins.  AF 568 (1 mg) 
was dissolved in 0.1 mL DMSO (dimethyl sulfoxide, Sigma-Aldrich, St. Louis, MO) and 
then mixed with dextran solution. After 4 hrs incubation, the resulting conjugate was 
separated from the unreacted dye by overnight dialysis using Slide-A-Lyzer™ dialysis 
cassette (MWCO = 3 000; Pierce Inc. Rockford, IL).  The AF568 to dextran ratio was 
demonstrated to be between 66 and 68 on the basis of the known dextran concentration, 
the assumption of 15% loss of dextran, and the AF568 excitation spectra.  For 
simplification, in the remainder of this contribution, the dextran-donor or acceptor-ConA 
concentrations are denoted on the basis of moles of dextran or ConA. 
4.2.2 Excitation and Emission Spectra. 
Steady-state fluorescence measurements were made using a SPEX Fluorolog II 
spectrofluormeter (HORIBA Jobin Yvon Inc. Edison, NJ).  The excitation wavelength 
was 568 nm and emission was collected from 588 nm to 720 nm in 2 nm increments and 
with a 1 sec integration time.  The sample solution was held in semi-micro cells (Starna 
Cells Inc., Atascadero, CA) with right-angle observation and central illumination. 
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4.2.3 Frequency-domain Lifetime Spectroscopy Measurements.   
Lifetime measurements were conducted with a frequency-domain lifetime 
spectroscopy system previously described (30,136).  Briefly, a continuous wave (CW) 
light (568 nm) from a wavelength tunable Ar-Kr mixed gas laser (model 643, Melles 
Griot, Boulder, CO) was modulated by an external electro-optic modulator (EOM) 
(model 350-160, Conoptics, Danbury, CT).  The photodetectors were two 
photomultiplier tubes (PMT, model H6573, Hamamatsu, Tokyo, Japan) that were gain-
modulated by an amplified RF signal from a master frequency synthesizer (PTS310, PTS 
Inc., Littleton, MA).  The master frequency synthesizer was phase locked to another 
slave frequency synthesizer (Marconi Instruments Signal Generator 2022A, Mountain 
View, CA) which drove the EOM at the same frequency plus an offset of 100 Hz for 
heterodyne detection.  A portion of the incident excitation light was directed to a 
reference PMT which was outfitted with a long pass filter (LPF550, CVI laser, 
Albuquerque, NM) which slightly improved the measurement of the reference excitation 
signal.  The sample PMT was outfitted with long pass filter (LPF500, CVI laser) and 
band-pass filter (600 nm, 8 nm FWHM, CVI laser) to collect the fluorescence light from 
the sample.  For each sample of varying acceptor-ConA or glucose concentration, the 
phase-shift and modulation-ratio were taken at the sample PMT as a function of 
modulation frequency (45 to 135 MHz) and reported relative to the reference PMT.  For 
the fluorophores employed, the useful modulation frequency range of 35-145 MHz 
enabled collection of sufficient data for evaluation of decay kinetics (30).  The reference 
fluorophore of AF568 (with lifetime of 3.6 ns (141)) was used to correct the 
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instrumentation response function according to the methods described elsewhere (123).  
We measured the lifetime of free and conjugated AF568 and found that the AF568 
lifetime remained constant at 3.6 nsec and was unchanged with conjugation.  
4.2.4 Optimization of FRET Affinity System.   
One of the advantages of the ConA-dextran system is the flexibility of (i) 
measuring either donor or acceptor emission, (ii) changing the donor-dextran 
concentration; and (iii) changing the acceptor-ConA concentration in order to change the 
sensitivity and sensing range (48,52,108).  To optimize the AF568/AF647 dextran-ConA 
FRET system for maximum sensitivity to glucose concentrations ranging from 0 to 200 
mg/dL and sensing range up to 700 mg/dL, we (i) evaluated changes in donor-dextran 
and acceptor-ConA fluorescence intensities as a function of glucose concentration up to 
500 mg/dL in order to choose the most sensitive FRET measurement wavelength for 
monitoring changes in glucose, and once determined, (ii) assessed its emission intensity 
as a function of concentration in order to maximize measurement sensitivity and 
minimize attenuation owing to inner filter effects.  Next, at the optimal concentration of 
the conjugated FRET dye, we evaluated the most sensitive concentration of the 
corresponding conjugated FRET dye needed to achieve the desired sensing range and 
sensitivity by monitoring the changes in phase-shift from frequency-domain lifetime 
spectroscopy.   From all of these intensity and frequency-domain measurements, we 
determined the optimal emission wavelength as well as the optimal donor-dextran and 
acceptor-ConA concentrations for evaluating the FRET decay kinetics as described 
below. 
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4.2.5 Evaluations of FRET Decay Kinetics from Frequency-domain Measurement.   
At the optimal donor-dextran concentration determined from the above 
procedures, aliquots of 46.24 µM acceptor-ConA solution were added in six increments 
to render the final optimal acceptor-ConA concentration determined from the above 
procedures.  Thirty seconds after each aliquot addition, frequency-domain fluorescence 
lifetime measurements were conducted.   Measurements were performed with duplicate 
samples and each measurement was conducted 4 times on each sample.    
At the optimal donor-dextran and acceptor-ConA concentrations, aliquots of 300 
mg/dL glucose solution were added in five increments to render a final glucose 
concentration of 224 mg/dL.  Thirty seconds after each aliquot addition of glucose, 
frequency-domain fluorescence lifetime measurements were conducted.   Measurements 
were performed with duplicate samples and each measurement was conducted 4 times 
on each sample.    
In this study, we assumed FRET decay kinetics model follows the generalized 
Förster model as shown in Equation 3.8. By taking the Fourier transform of Equation 3.8 
and taking the real and imaginary parts to predict the frequency-domain measurements 
of phase and amplitude modulation (26), the measurements can be related in terms of a 
function of α, β, and γ.  These parameters were determined from the best fit between 
model predicted values (θP and MP) and experimental values (θM and MM ) as indicated 
by χ2 (142).  
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While Equation 3.8 was used to evaluate the FRET decay kinetics, we also 
evaluated the FRET changes in terms of an average lifetime, τavg (30).  
4.3 Results 
4.3.1 Donor and Acceptor Characterization   
Figure 4.1 illustrates the excitation and emission spectra for the AF568 and the 
absorption and emission spectra for AF647 dye pairs.  The Förster distance for the dye 
pair is 82 Å (141) and is larger than that for all other dye pairs previously reported in 
literature (4,5,10)  as shown in Table 4.1.  In addition, the molecular weight of both 
AF568 and AF674 is less than 1300 Da and more consistent with the “point dipole” 
assumption of Förster theory (99) than that of other studies employing high molecular 
weight dye pairs found in the literature (110,138).   Finally, we found the Alexa Fluor 
dyes to be most photo-stable and pH insensitive, with good solubility in aqueous 
solutions (141). Table 4.1 presents the fluorescence properties of the AF568/AF647 
donor-acceptor pair. 
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Figure 4.1. Normalized excitation (dashed line) and fluorescence (dashed dotted line) 
spectra of AF568-dextran (donor-dextran) and the normalized absorption (solid line) and 
fluorescence (dotted line) spectra of AF647-ConA (acceptor-ConA).  For clarification 
and simplification, the donor or acceptor concentrations were denoted as the 
concentration of dextran or ConA in the entire dissertation.  
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Table 4.1. Fluorescence properties for different donor-acceptor FRET pairs used in our 
experiments and other literature: 
D-A 
Pairs Ex/Em(nm) 
є (M-1cm-1, 
peak value)e 
τ (ns) MW R0 (Å) 
Labeling 
ratio 
AF633 
(D) 632/646 159000 3.2
d 1200e 1.6:1 = D: Con A 
QSY21 
(A) 704/NA 89600 NA 815
e 
73a 
6.1 = A: 
dextran 
AF568 
(D) 578/602 88,000 3.6
d 791e 66:1 = D: dextran 
AF647 
(A) 649/666 250,000 1.4
d 1300e 
82a 
2.8:1 = A: 
Con A 
Cy5 (D) 646/664b 2.5×105 1.4b 1200b 1:1 = D: Con Ab 
MIMG 
(A) 584/NA
b 30,000 NA NA 
35b 
1.5: 1 =A: 
dextranb 
APC (D) 650/670 2.4×106 1.8c 104,000c 1.1:1 = D: Con Ac 
MG (A) 620/NAc 78500 NA 485e 
59c 
1:1=A: 
dextranb 
AF647 
(D) 649/666 250000 1.4
d ~1400e NA 
QSY21 
(A) 704/NA 89600 NA 815
e 
80a 
NA 
a used PhotochemCAD software; bdata were provided by Tolosa et al. (51);cdata were 
provided by Rolinski et al. (50); dlifetime data were provided by Molecular Probes Inc; 
eextinction coefficient and molecular weight data were provided by Molecular Probes 
Inc. (141) 
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4.3.2 Optimization of the ConA and Dextran Affinity System 
Figure 4.2 illustrates the donor fluorescence intensity (diamonds) and acceptor 
fluorescence intensity (squares) for a solution of 3.75×10-2 µM dextran-donor and 4.95 
µM acceptor-ConA concentrations as a function of added glucose in the solution.   The 
results show that as the glucose competitively replaces the dextran from ConA binding, 
the transfer of energy from the donor decreases resulting in increased donor fluorescence.   
Unexpectedly, but similar to the results obtained by Meadows and Shultz (108), the 
acceptor emission increased, due perhaps to reduction of self-quenching.  Upon 
comparing the intensity change of donor and acceptor emission with varying glucose 
concentration, it is seen that the measurement at the donor emission wavelength has 
greater sensitivity to glucose concentration than measurement of the acceptor emission.  
For this reason, the donor fluorescence was monitored in all subsequent measurements. 
Figure 4.3 is a plot of the donor fluorescence at 602 nm as a function of the 
donor-dextran concentration in the absence of acceptor or glucose.  As the concentration 
of donor-dextran increases beyond 0.09 µM, fluorescence decreases.  We hypothesize 
that this effect is owing to the inner filter effects which distort the fluorescence spectra at 
higher concentrations.  It is also noteworthy that a limitation in the concentration of 
donor-dextran is reached in this free, non-immobilized system by precipitation of the 
conjugate due to a strong multivalency interaction (122).  Consequently, the donor-
dextran concentration in this affinity system should be 0.09 µM or lower for optimal 
measurement sensitivity.  All subsequent measurements were conducted at a donor-
dextran concentration of 0.09 µM or lower. 
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Figure 4.2. Donor (left) and acceptor (right) fluorescence intensity change (a.u.) at 602 
and 680 nm resulting from excitation at 568 nm as a function of glucose concentration 
(mg/dL).  The donor concentration was 0.0375 µM; and the acceptor concentration was 
4.95 µM.   Symbols denote measurements while the trend lines connect measurements.  
 
 
 
4
4.5
5
5.5
6
6.5
7
0 100 200 300 400
Glucose concentration (mg/dL)
D
on
or
 fl
uo
re
sc
en
ce
 in
te
ns
ity
 
(a
.u
.)
1
1.5
2
2.5
3
3.5
4
A
cc
ep
to
r f
lu
or
es
ce
nc
e 
in
te
ns
ity
 (a
.u
.)
602nm donor emission
680nm acceptor emission
76 
 
Figure 4.3. Normalized donor fluorescence intensity (a.u.) at 602 nm following 
excitation at 568 nm as a function of donor-dextran concentration (×100 µM). The 
symbols denote experimental measurements and the dotted line is the linear fit at low 
donor concentrations. At donor-dextran concentrations above 0.09 µM (denoted by 
dotted line), inner filter effects distort the fluorescence spectra.   
 
 
Figure 4.4 illustrates an example of the phase-delay measured at 110 MHz of the 
donor fluorescence as a function of glucose concentration for two different acceptor-
ConA concentrations of 4.95 and 8.25 µM at a constant donor-dextran concentration of 
0.0375 µM.  These results show that upon increasing the acceptor-ConA concentration 
from 4.95 (open circles) to 8.25 µM (closed circles), the glucose sensing range is 
expanded but with reduced sensitivity at the lower glucose concentration which might 
better detect the life-threatening hypoglycemia.  Our findings differ from previous 
reports which show no change in sensitivity with increasing ConA concentration (48).   
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Figure 4.4. The phase-shift (degrees) at 110 MHz of donor emission at 600 nm in 
response to excitation at 568 nm as a function of glucose concentration (mg/dL). 
Symbols denote measurements for acceptor concentration of 4.95 µM (open circles) and 
8.25 µM (filled circles) at a donor-dextran concentration of 0.0375 µM.  The lines 
connecting the measurements indicate the trend lines. 
 
 
4.3.3 FD Measurements of FRET Changes with Adding Acceptor-ConA and Glucose 
Figure 4.5 and Figure 4.6 present the phase-shift and modulation-ratio of the 
donor emission as a function of modulation frequency for a solution with donor-dextran 
concentration of 0.09 µM with incremental concentrations of added acceptor-ConA.  
Error bars were calculated using the standard deviation of eight measurement results.  
Measurements were conducted with concentration ratios of acceptor-ConA to donor-
dextran up to 118:1.  As the concentration of acceptor-ConA increases, the binding of 
ConA to dextran (i) reduces the average distance between donor and acceptor molecules, 
(ii) increases energy transfer between the FRET pair, and (iii) reduces the lifetime of the 
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donor molecule.    If one considers a mean lifetime change in which we used an average 
lifetime decay kinetics model ( 1 10tan ( ) tan ( )avgθ ωτ ωτ− −∆ = − (26)), then a ~21% 
increase in donor lifetime (i.e. ( ) /o avg oτ τ τ− ) occurs when the acceptor-ConA 
concentration increases from 0 to 10.67 µM.  Here we define 0τ as the unquenched 
donor lifetime (3.6 ns) and τ  as the donor lifetime at certain acceptor-ConA 
concentration. 
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Figure 4.5. The phase-shift (degree) at 600 nm in response to excitation at 568 nm as a 
function of modulated frequency (MHz) with increasing acceptor-ConA concentrations 
as indicated in the legend. The symbols denote the average of n=8 measurements at 
various acceptor-ConA concentrations; the error bar denotes standard deviations; and the 
dotted line denotes a trend line. The donor-dextran concentration was 0.09 µM. 
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Figure 4.6. The modulation ratio at 600 nm in response to excitation at 568 nm as a 
function of modulated frequency (MHz) with increasing acceptor-ConA concentrations 
as indicated in the legend. The symbols denote the average of n=8 measurements at 
various acceptor-ConA concentrations; the error bar denotes standard deviations. The 
donor-dextran concentration was 0.09 µM. 
 
 
In our second experimental step, glucose concentrations were increased to 
competitively replace the dextran binding to ConA and thus change the distance between 
the donor and acceptor in the system (50).  Figure 4.7 and Figure 4.8 illustrate the phase-
shift and modulation ratio of the donor emission as a function of modulation frequency 
at increasing glucose concentrations for a solution with donor-dextran concentration at 
0.09 µM and the acceptor-ConA concentration at 10.67 µM.  As the glucose 
concentration increases, dextran binding to ConA is displaced by glucose which (i) 
increases the average distance between donor and acceptor molecules, (ii) decreases 
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energy transfer between the FRET pair, and (iii) increases the lifetime of the donor 
molecule.   If one considers a mean lifetime change, then a ~13% increase in donor 
lifetime occurs when the glucose concentration increases from 0 to 224 mg/dL.  While 
the refractive index as well viscosity of highly concentrated ConA-dextran solution 
could impact decay kinetics (20,143,144), the influences of viscosity and refractive 
index change are negligible at the concentrations used herein.  Based on the 
experimental results shown in Figure 4.7 and Figure 4.8, we extracted parameters α, β, 
and γ in the donor decay kinetics model using Equations 3.8 and 3.16. 
4.3.4 FRET Decay Kinetics of Donor-dextran in Response to Increasing Acceptor-ConA 
and Glucose Concentrations   
Figure 4.9 illustrates the parameter estimates of γ, β, and α as a function of 
acceptor-ConA concentration for the fluorescence lifetime phase-shift data presented in 
Figure 4.5 as well as the modulation ratio data presented in Figure 4.6.  Figure 4.9(a) 
shows an increase in the parameter γ with increasing acceptor-ConA concentration 
consistent with enhanced FRET.  Table 4.2 (a) lists the change of average donor lifetime, 
τavg, and parameter γ at increasing acceptor-ConA concentration.  We find the percentage 
change of the mean lifetime (∆τ/τ0~21%) is smaller than the percentage change of γ with 
increasing acceptor concentration (~70%, ∆γ/γmax, where γmax is parameter value at 10.67 
µM of acceptor-ConA concentration).  Figure 4.9(b) demonstrates that parameter β does 
not appear to systematically vary with acceptor concentration, but differs from the values 
expected for freely diffusible donor and acceptor encountered in two and three 
dimensions (0.27 ± 0.18).  Figure 4.9(c) also shows that the value of α does not vary 
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with acceptor concentration.  The average value of α in Figure 4.9(c) is 3.76 ± 0.13 ns 
which is close to the unquenched lifetime of 3.6 ns.  The small difference may be due to 
change of donor lifetime after conjugation with dextran.  
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Figure 4.7. The phase-shift (degree) at 600 nm in response to excitation at 568 nm 
versus modulation frequency (MHz) as a function of increasing glucose concentration 
(mg/dL) as indicated in the legend.  The symbols denote the average of n=8 
measurements at various glucose concentrations; the error bar denotes standard 
deviations; and the short-dash line denotes a trend line.  The donor-dextran concentration 
was 0.09 µM, and the acceptor-ConA concentration was 10.67 µM. 
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Figure 4.8. The modulation ratio at 600 nm in response to excitation at 568 nm versus 
modulation frequency (MHz) as a function of increasing glucose concentration (mg/dL) 
as indicated in the legend.  The symbols denote the average of n=8 measurements at 
various glucose concentrations; the error bar denotes standard deviations.  The donor-
dextran concentration was 0.09 µM, and the acceptor-ConA concentration was 10.67 µM. 
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Figure 4.9. Parameter estimates of (a) γ (dimensionless), (b) β (dimensionless) and (c) α 
(ns) as a function of acceptor-ConA concentration, based on the concentration of dextran 
is equal to 0.09 µM.  The symbols denote the average values calculated from calculated 
average phase-shifts and modulation-ratios.  The error bars denote standard deviations 
determined from the standard deviations of phase-shifts and modulation-ratios.  The 
dotted lines are the linear fits. 
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Table 4.2. Comparison of the change of donor average lifetime and the change of 
parameter γ with (a) increasing acceptor-ConA concentration; (b) increasing glucose 
concentration.  Average lifetime values are calculated from phase-shift data, assuming 
single-exponential decay kinetics. 
(a)   
acceptor-ConA 
concentration (µM) 
average lifetime 
(τavg, ns) γ 
0 3.60 0 
2.20 3.39 0.07 
4.20 3.12 0.17 
6.03 3.02 0.21 
7.70 2.89 0.52 
9.25 2.84 0.35 
10.67 2.79 0.37 
(b)     
glucose concentration 
(mg/dL) 
average lifetime 
(τavg, ns) γ 
0 2.79 0.37 
32 2.87 0.28 
64 3.03 0.05 
96 3.05 0.19 
160 3.15 0.13 
224 3.16 0.12 
 
 
Figure 4.10 illustrates the parameter estimates of γ, β, and α as a function of 
glucose concentration for the fluorescence lifetime phase-shift data presented in Figure 
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4.7 as well as the modulation ratio data presented in Figure 4.8.  Figure 4.10(a) shows 
that γ decreases with increasing glucose concentration, consistent with decreased FRET 
associated with competitive displacement of dextran from ConA.  Table 4.2 (b) lists the 
average donor lifetime, τavg, and parameter γ at increasing glucose concentration.  Upon 
comparing with the percentage change in mean lifetime (∆τ/τ0~13%), one finds that the 
percentage change of γ with increasing glucose concentration from 0 to 224 mg/dL is 
approximately 67% (∆γ/γmax).  Figure 4.10(b) demonstrates that parameter β does not 
systematically vary with glucose concentration, but expectedly differs from the values 
expected for freely diffusible donor and acceptor encountered in two and three 
dimensions (0.30 ± 0.11).  Apparently the dimensionality of the affinity system has been 
changed.  However more experiments data are required to explain the change in β.  The 
average value of the term α in Figure 4.10(c) is also 3.76 ± 0.18 ns, again consistent with 
the unquenched lifetime of the donor. 
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Figure 4.10. Parameter estimates of (a) γ (dimensionless), (b) β (dimensionless), and (c) 
α (ns) as a function of glucose concentration, based on the concentration of dextran is 
equal to 0.09 µM and the concentration of ConA is equal to 10.67 µM respectively.  The 
symbols denote the average values calculated from calculated average phase-shifts and 
modulation-ratios.  The error bars denote standard deviations determined from the 
standard deviations of phase-shifts and modulation-ratios.  The dotted lines are the linear 
fits. 
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Both Figure 4.9 and Figure 4.10 show that parameter γ may be used to 
quantitatively measure the FRET effects.  While phase-shift could be used to directly 
determine changes of glucose concentration as shown by others, we find that γ as 
opposed to phase-shift change at a single modulation-frequency (i.e. Figure 4.6) may 
increase the sensitivity of measurements of glucose concentration.  Our observation is in 
agreement with Rolinski and coworkers (50).  More results are needed to understand the 
changes in β, as the dimensionality of the pair distribution function of the conjugated 
acceptor and donor cannot be assumed to be a random in three-dimensions (50).  
In contrast to previous reports by Rolinski et al. (50) in which they found binding 
equilibrium at long times after addition of MG-dextran  to APC-ConA, we did not find a 
change of FRET decay kinetics with time using frequency-domain measurements 30 
seconds after adding AF647-ConA to AF568-dextran.  This observation indicates that 
the ConA-dextran complex forms immediately after addition as described by Tolosa, et 
al. (51).  In another system employing Rhodamine 6G and MG as a FRET pair, Porter, et 
al. (145) also found rapid equilibrium of binding as indicated by FRET decay parameters. 
Thus, dynamic change of FRET in the APC-MG system seen by Rolinski, et al. (50), 
could indicate that the FRET between APC and MG is due not only to the binding of 
ConA to dextran, but perhaps due to interactions between APC and MG. 
We also evaluated the existence of FRET effects between free AF568 and AF647 
in solution and found none, again an inconsistent result compared to that reported by 
Rolinski et al. (138).  Considering the smaller size and lower concentration of our 
donor/acceptor pair in comparison to the APC/MG FRET pair, this result is not 
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surprising.  However our findings confirm the lack of molecular interaction between 
AF568 and AF647 that may have existed between free APC and MG (110).   
4.4 Summary 
We have shown that frequency-domain measurements can be used to extract 
FRET decay kinetic parameters to quantify glucose concentration using the ConA-
dextran affinity system in a non-scattering solution over the range of 0 – 224 mg/dL.   
While using parameter γ could possibly provide better sensitivity for evaluating glucose 
concentration than the raw measurement of phase-shift, it is the simplicity of frequency-
domain measurements which promises a potential, low-cost sensing instrument using 
long-lived fluorophores as proposed by others (146,147) as well as short-lived 
fluorophores whose lifetimes are on the same order of magnitude as the photon “time-of-
flight” in tissues.  In order to deploy frequency-domain techniques with an implantable 
ConA-dextran sensing device, the time delays attributable to the decay kinetics of the 
ConA-dextran fluorescence affinity system will need to be distinguished from photon 
“time-of-flights” that arise from the optical properties of tissue.  Our work continues to 
accurately extract the kinetic decay parameters γ from multiply scattered donor 
fluorescence emanating from an implanted sensor in order to quantify glucose 
concentrations in vivo. 
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5. MICROSPHERE-BASED IMPLANTABLE OPTICAL SENSORS FOR PH∗ 
5.1 Introduction 
Optical methods offer unique opportunities for in situ, biomedical sensing of 
tissue analytes and metabolites owing to economics, avoidance of sample contamination, 
and in the case of fluorescence, exquisite sensitivity.  Fluorescence lifetime spectroscopy 
techniques furthermore possess advantageous insensitivity to sensing fluorophore 
concentration, photobleaching, and instrument artifacts (142), yet have not been widely 
deployed as a means for ultrasensitive detection of analytes and toxins. 
Fluorescence lifetime spectroscopy consists of exciting a fluorophore, whose 
lifetime is sensitive to an analyte (e.g. pH, Ca2+, O2, glucose, etc.) of interest, with 
intensity-modulated excitation light.  Upon activation, the fluorophore remains in an 
excited state for a mean period of time known as its 'fluorescent lifetime' (τ) before 
relaxation to the ground state either non-radiatively, or radiatively through the release of 
a fluorescent photon.  Owing to the picosecond/nanosecond lifetime of most 
fluorophores, the fluorescence signal generated in response to the intensity modulated 
excitation light is modulated at the same frequency as the excitation light, (i.e., in the 
order of 100 MHz), but is phase-shifted (θ) by as much as ninety degrees and amplitude-
attenuated (M).   
___________ 
∗ Part of this section is reproduced in part with permission form “Fluorescence lifetime spectroscopy of a 
pH-sensitive dye encapsulated in hydrogel beads,” by Eddy Kuwana, Feng Liang, and Eva Sevick-Muraca, 
Biotechnology Progress, 2004, 20, 1561-1566. Copyright 2004 American Chemical Society. 
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Typically, these frequency-domain or 'phase-modulation' measurements are 
conducted on diluted, non-scattering samples (54,125) and require a 'reference' 
measurement in order to account for temporal instrument artifacts (142).  Fluorescence 
intensity and lifetime-based measurements are the basis of chemical sensor or 
‘minimally invasive’ biosensor design employing exogenous fluorophores.  These 
designs generally consist of fluorescent dye embedded within a polymer matrix or semi 
permeable membrane placed at the tip of an optical fiber (148-150).  Immobilization of 
sensing fluorophores for in vivo diagnostics is necessary owing to their potential toxicity 
as well as the need to make repeated analyte/metabolite measurements.  PEG-based 
polymers, which are potential candidates for immobilizing sensing fluorophores, have 
previously been investigated as in vivo protein drug delivery devices, preventive agents 
for post surgical adhesion formation, and biocompatible membranes over 
electrochemical sensors (151). 
Russell et al. successfully synthesized optically transparent PEG hydrogel 
spheres in order to encapsulate a glucose sensitive FRET fluorophore system (40).  They 
studied the FRET fluorescence intensity response from this immobilized system at 
various glucose concentrations in buffered solutions.  However, intensity-based 
fluorescence measurements are susceptible to variations in fluorophore loading and 
when implanted in situ within tissues, they are sensitive to variations in tissue optical 
properties.  Since fluorescence lifetime is an intrinsic property of the fluorophore 
molecule, it is insensitive to the fluorophore concentration and excitation source 
intensity.  Nevertheless, determination of fluorescence lifetime in scattering media (such 
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as tissues) is distorted due to the “time-of-flight” associated with the migration of light.  
Hence, fluorescence lifetime spectroscopy of implantable sensors requires a model 
which accounts not only for fluorescence decay kinetics, but also photon propagation 
due to the tissue scattering. 
In previous work, we have demonstrated the enhanced sensitivity of fluorescence 
lifetime spectroscopy in the presence of multiple scattering that occurs in the NIR 
regime by means of the FDPM technique (123).  Specifically upon using a mixture of 
long lifetime DTTCI (1.33 ns) and shorter lived ICG (0.5 ns) dyes, we demonstrated that 
the small differences in frequency-domain or phase-modulation measurements of phase-
shift and amplitude-attenuation of generated fluorescence light can be amplified by the 
presence of multiple scattering caused by tissue mimicking scattering.  Furthermore, 
upon adapting a coupled photon diffusion equation to describe (i) the stochastic 
excitation and emission light propagation and (ii) the kinetics of fluorescence generation, 
we have demonstrated the ability to measure fluorescence lifetime from phase-shift 
measurements in multiply scattering solution.  In another study, we have demonstrated 
the proof of principle by successfully obtaining average lifetime in tissue-like scattering 
solutions of a pH sensing fluorophore, carboxy seminaphthofluorescein-1 (C-SNAFL-1) 
(136).  In this present study, we seek to develop implantable biosensor consisting of C-
SNAFL-1 immobilized in PEG hydrogel and perform fluorescence lifetime measurement 
within multiply scattering solutions.   
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5.2 Materials and Methods 
5.2.1 Dyes and Solutions 
The pH sensitive fluorescence dye, C-SNAFL-1 ester was obtained form 
Molecular Probes (Eugene, OR) and used as received.  C-SNAFL-1 has been shown to 
exhibit single-exponential and two-exponential decay kinetics at solution pH of 4.9 and 
9.3, respectively (125).  MOPS (3-(N-morpholino) propanesulfonic, Sigma-Aldrich, 
Milwaukee, WI) buffer solution was used to condition the sample pH, and in the case of 
measurements within a scattering medium, polystyrene (dialyzed Dow 788, particle size 
143 ± 22 nm, Dow Chemical Co., Midland, MI) was added.  By employing different 
MOPS salt concentrations, we varied the pH between 7 and 9 in both dilute MOPS (non-
scattering) and MOPS/polystyrene (scattering) solutions, while 5 mM buffer strength 
was maintained.  Carboxy seminaphthofluorescein-2 (C-SNAFL-2) (Molecular Probes, 
Eugene, OR) dissolved in PBS buffer at pH 4.9 (± 0.1) was employed as a reference dye 
for phase-modulation measurements in the non-scattering solutions. 
We conjugated SNAFL to a sugar binding protein, ConA, which was covalently 
bond to PEG prior to photopolymerization to form hydrogel beads containing the 
immobilized pH sensing fluorophore.  
Poly(ethylene glycol) diacrylate (PEG-DA) with a molecular weight of 575; 2-
hydroxy-2-methylpropiophenone (HMP, photoinitiator); Trimethylolpropane triacrylate 
(TPT, crosslinker); ConA (Type V); and DMSO were obtained from Sigma-Aldrich 
(Milwaukee, WI).  Acryl-PEG-NHS (α-acryloyl ω-N-hydroxysuccinimidyl ester of 
PEG-propionic acid) with a molecular weight of 3400 was obtained from Nektar 
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Therapeutics (Birmingham, AL).  Light and heavy paraffin oil and n-heptane were 
purchased from Fisher Scientific Inc. (Pittsburgh, PA).  All the reagents were used as 
received.  Phosphate-buffered saline (PBS, 1L, pH=7.2) consisted of 8 g NaCl, 0.2 g 
KCl, 1.44 g Na2HPO4 and 0.24 g KH2PO4.  Sodium bicarbonate buffer (NaB, 1L, titrated 
with HCl until pH=8.3) consisted of 8.4 g NaHCO3 and 29.2 g of NaCl.   
5.2.2 Synthesis of SNAFL-ConA 
The primary reagents for SNAFL-ConA conjugate consist of C-SNAFL-1 ester 
and ConA.  Prior to incubation, 10 mg of ConA was dissolved in 1 mL NaB (continuous 
shaking for 20 mins) and 1mg of C-SNAFL-1 ester was dissolved in 0.1mL DMSO.  The 
conjugation performed was similar to Haugland by mixing the dissolved ConA and C-
SNAFL-1 ester and incubating the mixture at room temperature for 4 hrs (141).  
SNAFL-ConA (labeling ratio was approximately 5) was produced due to the ester-amine 
reaction between ester of C-SNAFL-1 with the lysine present in ConA (141). 
5.2.3 Immobilization of SNAFL-ConA into Clear PEG Hydrogel 
The synthesis protocol for SNAFL immobilized in PEG was similar to that used 
by Russell et al. (40).  The primary reagents for immobilization of SNAFL-ConA in 
optically transparent PEG hydrogel (SNAFL-ConA-PEG) consisted of SNAFL-ConA, 
acryl-PEG-NHS, PEG-DA, TPT, and HMP.  The procedure to prepare the precursor 
solution was as follows: (i) SNAFL-ConA solution and 24 mg of Acryl-PEG-NHS were 
added to 8mL PEG-DA and the resultant mixtures were dissolved for 2 hrs while 
shaking (Daigger shaker, model 22406A, Vernon Hills, IL).  The ester of acryl-PEG-
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NHS reacted with the lysine present in SNAFL-ConA; (ii) 160 µL HMP and 960 µL 
TPT were added and the solution was mixed and shaken for another 30 mins; and (iii) 
the resulting precursor solution was then extruded through a 26G syringe needle (10 mL, 
Becton Dickinson, Franklin Lakes, NJ) using a syringe pump (model 100, KDScientific, 
New Hope, PA).  Compressed air was sprayed upon the solution droplets and to break 
the droplets apart into finer droplets.  The fine droplets fell into a bath of 1L mineral oil 
mixture (volumetric ratio of light oil to heavy oil was 1 to 3). The light and heavy oil 
mixtures were used to prevent agglomeration at the bottom section of the bath and to 
avoid long exposure to UV light (EFOS Ultacure 100SS Plus, output of 20 W/cm2) at the 
top section.  The photo-initiator photo-fragmented upon exposure to the UV light 
resulting in the production of highly reactive radicals.  These radicals induced gelation 
of the PEG chains into a hydrogel network by activating the acrylate groups.  Exposure 
to UV light was limited to seconds to minimize exposure and to complete 
polymerization as the precursor droplets descended down the mineral oil.  The resulting 
PEG spheres (SNAFL-PEG) were then rinsed with heptane and PBS.  The size of the 
particle can be controlled by proper adjustments of syringe pump volumetric rate and 
compressed air spray pressure.  The set-up for the polymerization process is shown in 
Figure 5.1. 
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Figure 5.1. Hydrogel preparation set-up where droplets of precursor solution were 
extruded through a syringe pump, sprayed with compressed air resulting into fine 
droplets that fell into mineral oil bath, and photopolymerized upon exposure to UV light 
at 365nm. 
 
 
Approximately 200 mL of SNAFL-PEG beads (35% void fraction) were 
produced.  The average diameter of the hydrogel particles was found to be 160 µm 
(Figure 5.2), as measured by a random sampling of 300 microsphere beads using Nikon 
microscope (Optiphot2-UD, Nikon, Melville, NY) equipped with stage micrometer.  The 
hydrogel product was then repetitively washed and dialyzed (in PBS) every 12 hours for 
a period of 3 days to remove the un-reacted SNAFL dye present in the hydrogel.  After a 
period of 10 days submersion in PBS, less than 1% of leakage in the SNAFL-PEG was 
found based on spectra intensity comparison between the hydrogel and the supernatant.  
The degree of penetrant diffusivities into cross-linked PEG hydrogel networks depends 
 
Precursor solutionCompressed air 
Mixed Mineral Oil
Syringe pump 
 PEG hydrogel
365 nm 
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upon the cross-linker concentration, size of PEG microspheres, and size of the penetrant 
molecules (42,152).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. (Top figure) PEG microspheres under Nikon microscope and (Bottom figure) 
size distribution of the PEG microspheres.  The bars in the size distribution plot indicate 
the fraction of the 300 randomly sampled beads with the corresponding diameter size.  
The line plot suggests that a normal size distribution with positive skew was attained.   
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In addition to SNAFL-PEG, we also prepared additional PEG hydrogels without 
SNAFL.  The gel samples for measurements in polystyrene scattering solutions 
consisted of 115 mL of SNAFL-PEG beads mixed with 85 mL PEG beads.  
Measurements in scattering polystyrene solutions were conducted within 200 mL sample 
containing 0.5% (by volume) polystyrene and MOPS buffers at various, measured pH 
values (7.7, 8.2, and 8.8).  Prior to performing measurements at a particular pH value, 
the hydrogels were washed with DI water and rinsed with the corresponding pH buffer.  
Excess of liquid was removed by vacuum filtration flask setup before addition of 
polystyrene and MOPS buffer having the desired pH value.   
5.2.4 Phase Shift and Modulation Measurements 
Measurements were performed using the FDPM method, as described elsewhere. 
(30,123)  Briefly, a continuous wave (CW) light from a wavelength tunable Ar-Kr mixed 
gas laser (Model 643; Melles Griot, Boulder, Colorado) at 514 or 647 nm wavelengths 
was modulated by an external electro-optic modulator (EOM) (Model 350-160, 
Conoptics, Danbury, CT) at modulation frequencies between 10 and 130 MHz.  The 
detectors consisted of two photomultiplier-tubes (PMT, Model H6573, Hamamatsu, 
Tokyo Japan) which were gain-modulated by a second oscillator for heterodyne 
operation.   
The PMT’s were outfitted with focusing lens assemblies as well as neutral-
density (CVI Laser, Albuquerque, NM) and narrow-bandpass interference filters (10 nm 
FWHM, CVI Laser) in order to optimize the amount of light detected at the incident 
wavelengths for excitation and emission measurements.  In addition, a long pass filter 
98 
 
(LPF 550, CVI Laser) was used to collect fluorescence in response to illumination at 514 
nm for measurement of fluorescence phase and modulation ratio (θM and MM) in 
scattering and non-scattering solutions. 
5.2.5 Measurements in Non-scattering Solutions 
For measurements in non-scattering solutions, light at 514 nm was used and 
fluorescence light was detected at right angles to the sample at 650 nm.  The fluorescent 
phase-shift and modulation-ratio (θf and Mf) of SNAFL-PEG submerged in MOPS buffer 
at differing pH, were measured as a function of modulation frequency (10 to 130 MHz).  
To correct for the instrument response, lifetime determination from phase-shift and 
modulation-ratio measurements in non-scattering solutions required 0.5 µM of carboxy 
seminaphthofluorescein-2 (C-SNAFL-2) in PBS buffer at pH 4.9 (±. 0.1) as a reference.  
The lifetime of C-SNAFL-2 at pH 4.9 is known to be 4.59 ns (125).   
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The phase-shift and modulation-ratio (θM and MM) of a dye that exhibits multi-
exponential decay kinetics in non-scattering media are functions of multi-exponential 
decay parameters as follows: 
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where aj is a pre-exponential factor representing the fractional contribution to the time-
resolved decay of the component with a lifetime τj.  For the case of two-exponential, n is 
equal to 2.  The values of aj and τj for a given sample can be estimated from 
measurements of phase-shift θ(ω) and modulation-ratio M(ω) by minimizing χ2, which is 
the error-weighted sum of the squared deviations between the measured and predicted 
values (142).  The Nelder-Mead method (153) can be used in order to minimize χ2 with 
respect to the parameters aj and τj. 
5.2.6 Measurements in Scattering Solutions 
For fluorescence measurements in scattering polystyrene solutions, fluorescence 
light at 650 nm was collected from a submerged fiber optic (1000 µm diameter, Thorlabs, 
Newton, NJ) located 1 cm and 1.6 cm away from a submerged fiber optic delivery of 
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modulated excitation light at 514 nm (123).  The multiplexing method described by 
Mayer et al. (30) was performed to eliminate instrument response functions for 
fluorescence measurements in the polystyrene scattering solutions.  Unlike non-
scattering measurements of lifetime, no reference dye was required.  In our study, the 
response time of SNAFL-PEG for changes of pH from 7.6 to 8.6 was found to be 
approximately 5 mins. 
In addition, using the same submerged collection and delivery fiber optics, 
measurements of phase-delay and amplitude-attenuation were made following 
illumination at both the excitation wavelength at 514 nm (θx and Mx) and emission 
wavelength (θm and Mm) at 650 nm.  Measurements were conducted as a function of 
modulation frequency as the distance between the illuminating and collecting fiber 
optics, (∆r), varied between 1.2 cm to 1.6 cm.  From these measurements, the optical 
properties of the scattering samples at the excitation (µax and µ'sx) and emission 
wavelength (µam and µ’sm) were determined for each scattering solution (123).  
The relationship between phase-shift θM detected at position r relative to the 
incident point of excitation light and average lifetime τavgscat of the sensing fluorophore 
has been derived from the optical diffusion equation in an infinite medium, and is shown 
as Equation 5.3: 
( , )
scat
avg
f scat
avg
B A
tan r
A B
ωτθ ω ωτ
+= −      (5.3) 
where the terms A and B are defined as Equations 3.30-3.35. 
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5.3 Results and Discussions 
Figure 5.3 shows the spectra of C-SNAFL-1 ester, SNAFL-ConA, and SNAFL-
PEG in PBS (pH 7.2) were obtained by SPEX FLUOROLOG II (HORIBA Jobin Yvon 
Inc., Edison, NJ).  The excitation spectrum was obtained with emission monochromator 
set at 650 nm; while in the case of emission spectra, the excitation monochromator was 
stationed at 514 nm.  While C-SNAFL-1 ester and SNAFL-ConA spectra are similar, 
SNAFL-PEG spectra are shifted to longer wavelengths. 
5.3.1 Fluorescence Multi-exponential Decay in Non-scattering Solutions 
The θM and MM values of SNAFL-PEG in non-scattering solutions are plotted in 
Figure 5.4 and 5.5 on pages 104 and 105 as a function of solution pH.  Similar to the free 
SNAFL, the decrease in phase and increase in modulation with increasing pH values is 
due to the increased relative contribution of the short-lived or de-protonated dye species 
at longer wavelengths (136).  It was found that the two-exponential decay kinetic model 
adequately fit the data.  The average lifetime for two-exponential fits, τavg, was 
calculated from the regressed parameters aj and τj from the following relationship: 
   
2 2
1 1 2 2
1 1 2 2 1 1 2 2
avg
a a
a a a a
τ ττ τ τ τ τ= ++ +     (5.4) 
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Figure 5.3. Excitation (emission at 570 nm) and emission (excitation at 514 nm) spectra 
of C-SNAFL-1 ester, SNAFL-ConA, and SNAFL-PEG in PBS (pH 7.2). 
 
 
5.3.2 Model Predictions of Multi-exponential Lifetime Decay in Scattering Polystyrene 
Solutions 
The θM and MM values of immobilized SNAFL-PEG in buffer/polystyrene 
solutions are plotted in Figure 5.4 and Figure 5.5.  The plots show a similar trend with 
pH as those observed in absence of scattering.  However, comparison of scattering and 
non-scattering plots shows that scattering contributes significantly to the phase-shift and 
modulation-ratio values.  The change in phase-shift and amplitude-attenuation with pH 
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was found in presence of scattering to be between 2 and 2.5 times larger than those 
changes in absence of scattering.  This result is consistent with our previous study using 
free SNAFL-1 (136) in scattering and non-scattering solutions. 
Comparison of non-scattering and scattering data also shows that scattering 
contributes significantly to the phase-shift values.  The solid lines in Figure 5.4 and 
Figure 5.5 denote the predictions using the two-exponential decay model incorporating 
the time delay of τavg and the regressed optical properties from excitation and emission 
measurements.  The plots show that the predicted values of θM and MM exhibit the same 
trend as that shown by the experimental data.  
Since the fluorescence data measured in the presence of scattering are in good 
agreement with the average lifetime model, fluorescence lifetime sensing of dyes 
exhibiting multiple decays may be performed by obtaining the average lifetime.  For the 
experimental scattering systems studied herein, the average lifetime of fluorescent dyes 
in scattering solutions can be most accurately predicted when the modulation frequency 
is in the order of 100 MHz.  It should be noted that consistent results were obtained (also 
shown in Table 5.1 as τavgscat (repeat)) when the experiment was repeated using the same 
hydrogels after one month storage at 5оC, confirming the reversibility and stability of 
immobilized C-SNAFL-1 dye in PEG hydrogels.  Approximately within two months of 
storage, less fluorescence signal could be detected and lifetime measurements were no 
longer repeatable. 
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Figure 5.4. The values of  fluorescence phase-shift, as a function of modulation 
frequency for SNAFL-PEG, where the plots in each figure consist of corrected 
experimental measurements (dotted lines) in non-scattering (bottom) and scattering 
solution (top) at various pH, and those predicted by the propagation model incorporating 
average lifetime (solid lines).  Samples were excited at 514 nm and the emission was 
observed at 650 nm. 
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Figure 5.5. The values of modulation-ratio, as a function of modulation frequency for 
SNAFL-PEG, where the plots in each figure consist of corrected experimental 
measurements (dotted lines) in non-scattering (bottom) and scattering solution (top) at 
various pH, and those predicted by the propagation model incorporating average lifetime 
(solid lines).  Samples were excited at 514 nm and the emission was observed at 650 nm. 
 
 
 
 
It should be noted that in the absence of scattering, sub-nanosecond lifetime 
detection is difficult at these low modulation frequencies (10-130 MHz).  The presence 
of scattering however, magnifies the measured phase-shift value, and hence increases the 
sensitivity of lifetime sensing at low modulation frequencies, given that the optical 
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properties of the medium can be accurately predicted.  Figure 5.6 depicts the 
fluorescence phase-shift values at different pH for both non-scattering and scattering 
measurement at 100 MHz.  The figure confirms that measurements in presence of 
scattering were not only magnified, but resulted in better resolution compared to those in 
absence of scattering.  Table 5.1 shows average lifetime values τavgscat that were 
recovered from phase-shift data acquired in presence of scattering, at 100 MHz using 
Equation 5.3.  The values are in agreement with the values of τavg obtained from phase-
shift measurements of C-SNAFL-1 in MOPS (non-scattering). 
 
Table 5.1. Average lifetime values calculated from phase-shift data (τavgscat) and from 
the repeated experimental data (τavgscat (repeat))  in presence of scattering, assuming two-
exponential decay kinetics, at a fixed frequency of 100 MHz, in comparison with the 
values obtained in dilute non-scattering solutions (τavg).  
pH τavg ± 0.05 (ns)  τavgscat ± 0.05 (ns) 
τavgscat ± 0.05 (ns)  
(repeat) 
7.7 2.89  2.86 2.91 
8.2 2.73  2.69 2.69 
8.8 2.50  2.47 2.49 
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Figure 5.6. Average standard deviation of phase-shift data in non-scattering and 
scattering, calculated over a range of modulation frequencies from 30 to 130 MHz in 5 
MHz increments with 3 measurements replicates experiment, at each pH value. 
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5.4 Summary 
We have demonstrated, for the first time, the applicability of FDPM for 
fluorescence lifetime spectroscopy of immobilized fluorophore in multiply scattering 
solutions.  The propagation of excitation and fluorescence light of a pH sensing dye, C-
SNAFL-1, immobilized within a PEG hydrogel, in scattering polystyrene solution could 
be well predicted from the average lifetime.  As a result, the measurement approach for 
conducting NIR fluorescence lifetime spectroscopy of immobilized dyes by means of 
light propagation model for is greatly simplified.  In addition, owing to the stability of 
the immobilized fluorescence sensor as well as the reliability of fluorescence lifetime 
measurement, the method presented in this study may provide a new approach for 
analyte or toxin screening.     
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6. MONTE CARLO MODELING OF FLUORESCENCE PHOTON 
MIGRATION IN MICROSPHERE-BASED IMPLANTABLE SENSORS 
6.1 Introduction 
Many efforts to develop noninvasive glucose sensors have focused upon 
microsphere-based implantable fluorescent optical sensors.  In this schema, (i) a glucose 
competitive binding ConA-dextran affinity system, or(ii) glucose oxidase and an 
oxygen-sensitive fluorophore are either chemically immobilized into the microsphere 
network or attached on the microsphere surface and then confined inside a sealed 
dialysis membrane (38,42,44).  The microspheres protect the fluorophore from 
interaction with other possible interfering substances from blood plasma or interstitial 
fluids.  They also increase the stability of affinity or glucose oxidase system and reduce 
potential toxicity by compartmentalizing the toxic dyes.  The microspheres applied in 
previous studies were PEG hydrogel (40), alginate-poly-L-lysine (119), Sephadex (43), 
Sepharose (44), polystyrene (46), and polyelectrolyte-coated alginate microparticles 
(55,115).   
Table 6.1 provides a cumulative summary of microsphere-based fluorescent 
optical sensors for glucose measurements.  All these studies used intensity-based 
fluorescence measurements.  However, other studies and our previous studies showed 
that lifetime measurements can provide an alternative measurement that might be 
advantageous over intensity measurements in several ways (30).  The lifetime-
measurements are not influenced by several confounding factors, such as: (i) variation of 
110 
 
immobilized fluorophore concentrations; (ii) fluorophore photobleaching; and (iii) 
instrumentation response function.  In our study, fluorescence lifetime measurements are 
carried out by using FDPM techniques (154).  Briefly, an intensity sinusoidally 
modulated laser light source is launched onto the surface of tissue or tissue-mimicking 
phantoms through an optical fiber.  Then the light is scattered and absorbed due to the 
absorption and scattering of the media.  The generated fluorescence light is again 
scattered and absorbed.  Finally the detected fluorescence signal through a detecting 
optical fiber is phase-delayed and amplitude attenuated relative to the incident excitation 
light.  The phase-shift and amplitude are the measured quantities as shown in Figure 3.2. 
In the first use of FDPM techniques for microsphere-based implantable sensor, 
we immobilized a pH sensitive dye into PEG hydrogel via ester-amine reaction and then 
placed the PEG microparticles (average particle size 160µm) into tissue-mimicking 
phantoms (58).  Measurements of phase-shift and amplitude of the multiply scattered 
fluorescent light were successfully obtained as a function of modulation frequency of the 
incident excitation light.  The results showed that at the presence of tissue scattering and 
absorption, the measured phase-shift value was magnified while the amplitude was 
decreased.  Since the experiments were carried out in a large volume of tissue-
mimicking phantom comparing with the size of PEG microparticles, a couple optical 
diffusion equations were applied to account for the photon propagation and to extract the 
lifetime change of this pH sensor. 
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Table 6.1. Review of literature involving microsphere-based fluorescence glucose sensor 
Reference Material Indicating fluorophore 
Particle 
size, 
diameter 
Immobilized 
system 
Wavelength 
(ex/em),nm Comments 
Russell et al. 
(1999) (40) PEG FITC 2 mm 
FITC-
ConA/TRITC-
dextran 
488/500-660 
demonstrated entrapment of FRET 
affinity system into PEG-based 
hydrogel 
McShane et al 
(2000) (41) PEG FITC N/A 
FITC-
ConA/TRITC-
dextran 
488/500-600 
demonstrated a fiber-optic system 
for delivery and collection of 
intensity signal 
McShane et al 
(2000) (155) PEG FITC N/A 
FITC-
ConA/TRITC-
dextran 
N/A 
demonstrated Monte Carlo 
simulation result of light 
propagation through human skin 
with an implantable fluorescent 
sensor 
Russell et al 
(2000) (119) 
Poly-L-lysine 
and calcium 
alginate 
FITC 2.5-3.5 mm 
FITC-Succinyl-
ConA/TRITC-
dextran 
488/>500 
demonstrated the use of calcium 
alginate gel and poly-L-lysine 
coating for entrapment of 
ConA/dextran 
Ballerstadt and 
Shultz (2000) 
(43) 
Sephadex G200 
and G150 with 
hollow fiber 
memberane 
(MWCO 10000) 
Alexa488 20-50 µm 
Alexa488-
ConA/Safranin 
O/Pararosanilin 
488/520 demonstrated the use of Sephadex and dialysis membrane 
Xu et al (2002) 
(97) 
PEBBLE 
nanoparticles 
Ru[dpp(SO3N
a)2]3Cl2 
45 nm 
GOX/ 
Ru[dpp(SO3Na)2]
3Cl2/Oregon 
Green 488-
dextran 
488 nm/>550 
demonstrated the use of PEEBLEs 
incorporating GOX, oxygen 
sensitive fluorophores, and oxygen-
insensitive fluorophores for 
intracellular glucose imaging.  The 
study used ratiometric measurement 
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Table 6.1 Continued. 
Reference Material Indicating fluorophore 
Particle 
size, 
diameter 
Immobilized 
system 
Wavelength 
(ex/em),nm Comments 
Ballerstadt et al 
(2004) (113) 
Sephadex G200 
and G150 with 
cellulose 
membranes 
(MWCO 6000-
8000) 
Alexa647 20-50 µm Alexa647-ConA 633/670 demonstrated increasing stability of 
ConA by immobilization of it on 
Sephadex, temperature influence, 
photobleaching activities of this 
sensor 
Ballerstadt et al 
(2004) (44) 
Sepharose with 
hollow dialysis 
fiber (o.d.215 
µm, wall 
thickness 20 µm 
Alexa647 45-165 µm Alexa647-
ConA/QSY21-
dextran 
647/670 demonstrated the use of long 
wavelength dye and immobilized 
ConA within Sepharose beads 
Chinnayelka 
and McShane 
(2004) (55) 
Layer-by-layer 
(LbL) self-
assembling 
polyelectrolyte 
microsphere 
FITC 5 µm FITC-
ConA/TRITC-
dextran 
488/500-600 demonstrated the use of LbL self-
assembling multiple-layer 
polyelectrolyte microsphere for 
immobilization of ConA-dextran 
affinity system 
Rossi et al 
(2004) (156) 
Fe3O4 
nanoparticles 
Ru(phen)3 20 nm GOX/Ru(phen)3 460/610 demonstrated the use of magnetite 
nanoparticle entrapping the GOX 
and oxygen-sensitive dyes. The 
study showed improved stability of 
GOX 
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Table 6.1 Continued. 
Reference Material Indicating fluorophore 
Particle 
size, 
diameter 
Immobilized 
system 
Wavelength 
(ex/em),nm Comments 
Yadavalli et al 
(157)(2005) 
PEG FITC ~100 µm FITC-
dextran/TRITC-
ConA 
488/>500 demonstrated MC simulation results 
for predicting optimum hydrogel 
optical properties, e.g. sphere size, 
gel chemistry, and scattering 
anisotropy 
Chinnayelka 
and McShane 
(83)(2005) 
Polyelectrode FITC 2.2-5.8 µm FITC-apo-
GOX/TRITC-
dextran 
488 />500 demonstrated the use of apoenzymes 
encapsulated into polyelectrolyte 
microbeads 
Brown et al 
(38)(2005) 
Polyelectrode 
coated calcium 
alginate 
Ru(dpp)/Alex
a488 
20-30  µm Alexa488/Ru(dp
p)/GOX 
460/500-640 demonstrated experimental results of 
calcium alginate microsphere 
entrapping oxygen-sensitive 
fluorophore and GOX 
Brown and 
McShane 
(47)(2006) 
Polyelectrode 
coated calcium 
alginate 
Ru(dpp)/Alex
a488 
N/A Alexa488/Ru(dp
p)/GOX 
460 nm/500-
640 
demonstrated a two-substrate math 
model for predicting the impact of 
several sensor parameters, e.g. 
sphere size, film thickness 
Chinnayelka 
and McShane 
(115)(2006) 
LbL-
polyelectrode 
Cy5 5 µm Cy5-apo-
GOX/TRITC-
dextran 
543/560-725 demonstrated the use of long 
wavelength Cy5 dye to replace 
previous FITC dye 
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In an actual implant of glucose sensing microparticles, Pishko and his coworkers 
showed that implanted polystyrene particles (15 µm in diameter) could be fairly dense 
packed in a small area at the dermis using insulin needles to inject (157).  The implanted 
microparticles were randomly distributed but closely packed between the dermis and 
epidermis.  The detected fluorescence light signal was influenced not only by the tissue 
scattering and absorption but also by the microsphere optical properties. Other 
parameters, such as particle volume fraction, particle size, particle refractive index, and 
particle configuration, also impacted the measurements. 
There are two unique features that exist in this implantable sensing system 
involving micrometer-sized particles:  
(i) Light propagation in this sensing area has two different speeds.  Outside 
microspheres, light travels at a velocity of c/ntis, where ntis is the refractive index of the 
tissue or tissue phantom; inside microspheres, light travels at a velocity of c/npar, where 
npar is the refractive index of the microspheres.  Table 6.2 lists the refractive index 
difference between different skin layers and polymer microspheres.  Figure 6.1 
illustrates the scheme of light propagation in ensemble of these densely packed 
microspheres.  
(ii) The particle size of implantable microspheres (dp) is much larger than the 
wavelength of incident light (λ).  It is well known that the near-infrared light has the 
potential to penetrate the skin deeply owing to the low absorption of blood, melanin, and 
water.  The wavelength of incident light used in this implantable sensor is preferably 
around 600-900 nm (27).  However, the size of microspheres may be from several 
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micrometers to several millimeters (40,157).  When particle size is 20 or more times 
larger than the wavelength, geometric optics may be used to account for light 
propagation (158).  In contrast to the use of Mie theory for small particles (159), where 
dp << λ, geometric optics can be used to describe light propagation when dp> λ.  
 
 
Table 6.2. The refractive index of different skin layers, polymer microspheres and TiO2. 
Name of layer/polymer microsphere Refractive index (n) 
stratum corneum 1.5 (160) 
living epidermis 1.34 (160) 
papillary dermis 1.4 (160) 
upper blood net dermis 1.39 (160) 
reticular dermis 1.4 (160) 
deep blood net dermis 1.38 (160) 
subcutaneous fat 1.44 (160) 
PEG microsphere 1.37 (155) or 1.57 (157) 
polystyrene microsphere 1.59 (161) 
titanium dioxide (TiO2) particle 2.4 (162) 
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Figure 6.1. Illustration of light propagation in large, densely-packed microspheres with 
significant refractive index difference with skin layers.  The light speed in the 
microspheres is c/npar, where npar is the refractive index of the microspheres; while 
outside microspheres, light travels at a velocity of c/ntis, where ntis is the refractive index 
of the tissue or tissue-mimicking media.  The reflection and refraction of light on the 
boundary follow geometric optics rules. 
 
 
Monte Carlo computational methods have been applied to a number of problems 
in light propagation problems where analytical solutions are not available due to 
complex geometries or boundary conditions as shown in Figure 6.1.  McShane and his 
coworkers applied MC modeling for time-invariant light propagation in an implanted 
slab of polymer sensor (155).  Their model was simply based upon a multi-layered MC 
code by Wang et al.(163) with added fluorescence generation into the program.  An 
eight-layer skin tissue model is used in the simulation.  Instead of considering as 
individual microspheres, the implanted sensor was modeled as a homogenous slab layer 
of polymer between epidermis and dermis.  The output fluorescence intensity was 
recorded as a function of tissue and sensor optical properties, and thickness of tissue and 
  
117
of sensor layers.  The spatial distribution of the fluorescence intensity signal was also 
investigated.  Even though no experimental results were compared with the generated 
MC results,   the simulation provided useful information for designing an appropriate 
optical detection system.  Yadavalli and his coworkers first developed a MC model to 
address the impact of microsphere characteristics such as particle size, scattering, 
fluorescent concentration on detected fluorescence intensity signal (157).   They 
experimentally measured the PEG microsphere isotropic scattering and absorption 
coefficients using an integrating sphere.  The microsphere packing followed a strict Face 
Centered Cubic (FCC) configuration with volume fraction of 0.74.   The time-invariant 
MC model considered: (i) the light propagation inside and outside the particle; (ii) 
generated fluorescence light inside the particle; and (iii) reduced fluorescence photon 
weight after FRET.  The model was again not validated by experimental results.  
Moreover, the refractive index difference between inside and outside microsphere sensor 
was not addressed.   
In this contribution, we describe a novel MC simulation that takes into account: 
(ii) two different light propagation speeds; (ii) geometric optics; and (iii) fluorescence 
lifetime within the implantable sensing system.  The MC simulation tracks the time-
resolved light propagation of both excitation and fluorescence light, and transforms the 
results into the frequency-domain using Fourier transform. As will be shown herein, 
FDPM experimental measurements of randomly packed resin particles confirm the 
simulation results of excitation light propagation.  This MC simulation was then used to 
examine the impact of particle physical properties and fluorophore lifetime on the 
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measurable fluorescence signals in frequency-domain, namely PS and amplitude (AC).  
The MC simulation employed a random packed microsphere configuration which was 
generated from a dynamic simulation (161). 
The organization of this section is as follows: In the Materials and Methods 
section, the new MC model for time-resolved light propagation is described in detail.  
Then the FDPM experimental set-up using resin microspheres for validation of the MC 
model is presented.  In the Results section, we first present experimental results which 
validated the MC simulation of excitation light propagation.  Then, the influences of 
particle size, volume fraction, refractive index, fluorescence lifetime on simulated 
frequency-domain measurements are presented and discussed. 
6.2 Materials and Methods 
6.2.1 Phantom and Microsphere Structure for MC Simulation 
For the purpose of simulation and experimental validation, the microspheres 
were packed into a cubic volume (4.3 cm×1 cm×1 cm).  The size of the cubic is same as 
the cuvette (Starna Cells Inc., Atascadero, CA).  The packing structure was generated by 
a dynamic simulation program which was developed by Pan et al. (161) and described 
elsewhere by Yang and his coworkers (164,165).  Briefly, in this dynamic simulation 
code, the Newton’s second law of motion was solved numerically to track the 
translational and rotational motion of each numbered particle as it interacted with 
surrounding neighboring particles.  Subsequently, the randomly packed particle structure 
at equilibrium was used to generate different particle configurations with varying 
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volume fractions and/or particle sizes by uniform expansion as described elsewhere 
(166).  It was well accepted that simulation of 1024 microspheres with periodic 
boundary condition could provide a statistically stable structure (165).  Based upon the 
generated microsphere structure, we simulated 4000 microspheres within a 40dp ×10dp 
×10dp cubic with periodic boundary conditions along x, y, and z directions. 
6.2.2 Descriptions of the MC Model with Geometric Optics 
Our MC model was modified from a previous MC model which tracked the 
excitation photon trajectories in an infinite and densely packed powder bed (161,166).  
The code for the Monte Carlo simulations was programmed in Fortran 77 and executed 
with a SUSE Linux operating system.  An infinitely narrow beam with 108 photons was 
launched in each simulation conducted on an AMD dual-CPU and dual-core Opteron 
2.8GHz workstation with 8GB RAM.  For 109 photons, the computational time was 
around 1.2×106 seconds. 
In the MC simulation, the information about a photon includes: (i) the photon 
position vector ( r
r
), (ii) its direction ( v
r
), (iii) its photon weight (w), (iv) net propagation 
time (t), and (v) the refractive index of the medium on which the photon is located (ntis 
or npar).  The program tracked the photon trajectories one by one.  A flowchart outlining 
the simulation is presented in Figure 6.2.  Briefly, the process of tracking a photon 
package is described below. 
Each excitation photon package, with unity weight, is launched on the surface of 
the cubic phantom.  The step size, s of the photon is decided by (i) the photon moving 
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direction , v
r
, (ii) positions of random-packed microspheres, and (iii) the boundary of the 
phantom.  
For both excitation and fluorescence photons, when the photon moves to the 
surface of a particle, the program decides whether the photon undergoes reflectance or 
refraction at each boundary.  The probability for reflection is determined from the 
Fresnel’s reflection coefficient R(θi): 
2 2
2 2
1 ( ) ( )( )
2 ( ) ( )
i t i t
i
i t i t
sin tanR
sin tan
θ θ θ θθ θ θ θ θ
⎡ ⎤− −= +⎢ ⎥+ +⎣ ⎦
  (6.1) 
where the subscripts i and t denotes the incidence and transmission.  θi and θt are the 
angles of incidence and transmission of photon on the boundary of particle, respectively. 
The angle θt is obtained from the Snell’s law: 
sin sinit i
t
n
n
θ θ=     (6.2) 
The random number generator used the routine ran2 described by Press et al. 
(153), which provides more than 2×1018 random numbers.  The separately generated 
random numbers (ς1- ς4 ) between 0.0 and 1.0 were used to decide:  
(i) Whether the photon underwent reflectance or refraction.  If ς1< R(θi), then the 
photon undergoes the reflection on the boundary. Otherwise, the photon underwent the 
refraction;  
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Figure 6.2. Flowchart of MC simulation  
At cuvette boundary?
Out of 
phantom?
Reflection/refraction on microsphere 
Set N=0 
N=N+1
Propagate photon
Calculate step size based upon distance to boundary of microsphere  
Propagate photon 
In microsphere?
Yes
Fluorescent photon?
No 
Generate fluorescence? 
Input total number of photon (Nt)
Yes
End
Yes
No
Yes
No
No
Yes
Last photon? 
Yes
No
No
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(ii) Whether an excitation photon is relabeled as a fluorescence photon when 
inside the microsphere.  If ς2< P, then the excitation photon is relabeled as fluorescence 
photon, where P is probability of fluorescence generation (range from 0 to 1).  
Otherwise, the photon maintains it identity as excitation photon.  The probability, P,  is 
the function of quantum efficiency of the fluorophore, Q; the extinction coefficients 
owing to fluorophores at the excitation wavelength,  ξaxf; and the fluorophore 
concentration  within the microsphere [C] (167): 
[ ]( )exp axfP Q C sξ= −     (6.3) 
(iii) The time delay td during the process of fluorescence is given by (168).   
( )3lnd avgt ς τ= −      
 (6.4) 
where the average fluorescence lifetime is defined as τavg; 
(iv) The propagation direction of the generated fluorescence photon.  Since 
fluorescence is isotropic, there is no preferential direction.  The random number ς4 is 
used to provide the isotropic fluorescence photon propagation: 
( ) ( )4 4x sin cosµ ς π ς π=     (6.5) 
( ) ( )4 4y sin sinµ ς π ς π=       (6.6) 
( )4z cosµ ς π=      
  (6.7) 
This simulation makes the following major assumptions which are applicable to 
previous experimental results of implantable, microsphere-based fluorescence sensors 
(40,58):  
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(i) The fiber optic light source is modeled as an infinite-narrow, unidirectional 
collimated source.  The source light is launched perpendicularly onto the phantom 
surface.  However, our program can simulate arbitrary direction of incident light as well;  
(ii) The fluorophores are immobilized inside the microsphere.  There is no free 
fluorophore or fluorophore conjugates in the surrounding medium;  
(iii) The absorption from the surrounding tissue is much less than the absorption 
of the microsphere.  Therefore the influence of absorption from the surrounding tissue is 
not addressed in this treatment. 
(iv) The photon weight, w , after each ith scattering step is attenuated by (161)  
( ) , ,    in the particleln
0                      in the surrounding medium
a x m i
pari
c t
nw
µ⎛ ⎤− ⋅ ⋅⎜ ⎥∆ = ⎜ ⎥⎜ ⎥⎝ ⎦
      (6.8) 
where the subscript x,m represents excitation and emission. The term µa is the absorption 
coefficient, and  it , represents the “time-of-flight” associated with the photon scattering 
step length;   
(v) The average lifetime of fluorophore, τavg, is used in the simulation; and  
(vi) The generated fluorophore photon can not be used to regenerate another 
fluorescent photon. 
As shown in Figure 6.3, every surface of the cubic phantom is divided into 
10×10 elements.  The MC simulation stores the location, time, position, and weight of 
both excitation and fluorescence photons that reach each detection element.  
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Figure 6.3. Schematic of the phantom for implantable cubic phantom used in MC 
simulation.  The dimension of the phantom is 43×10×10 mm3.  In the MC code, each of 
the six surfaces on the cubic phantom is divided into 10×10 elements.  MC simulation 
stores the detected both excitation and fluorescence photons with the “time-of-flight” of 
photon that reach each element.  Particularly, PS and AC at elements (1,5) to (10,5) on 
the detection surface as shown in the top figure are analyzed.  The source-detector 
distance for three positions (positions 4, 6, and 8) are r4≈10.7 mm, r6≈7.22 mm, r8≈12 
mm.  
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6.3 Experimental Section 
6.3.1  Materials  
Resin microspheres were chosen for the validation experiment because they have 
spherical shape and are nearly mono-disperse.  Resin samples were obtained from Bio-
Rad Lab (type AG 1-X8, Hercules, CA) without modification.  Figure 6.4 illustrates the 
micrographs of resin samples under a Nikon microscope (Optiphot2-UD, Nikon, 
Melville, NY).  The average diameter of the dry microspheres was found to be 74 µm 
(Figure 6.5).  Table 6.3 lists the physical properties of resin microspheres used in this 
study.  The absorption coefficient for random close packing (RCP) of resin microspheres 
was calculated from six times’ measurements in a large container (volume> 150mL) 
using FDPM measurements described by Sun et al. (154). 
 
 
 
Figure 6.4. Resin microspheres under Nikon microscope.  The average particle size is 
74 µm ±4 µm as found by measuring 300 randomly sampled beads.  
0.1mm
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Figure 6.5. Size distribution of the resin microspheres.  The bars in the size distribution 
indicate the fraction of the 300 randomly sampled particles with the corresponding 
diameter size.  The line plot suggests that a normal size distribution was attained. 
 
 
 
Table 6.3. Details of physical properties of resin samples 
Name Shape Average size (µm) 
Refractive 
index 
Absorption 
coefficient for 
RCP (cm-1) 
Volume fraction 
for RCP 
resin Spherical 74 1.59 (161) 0.0129 0.64 (161,169) 
 
 
 
6.3.2 Phantom for Implantable Optical Sensors  
A glass cuvette (Starna Cells Inc., Atascadero, CA, dimension 4.3×1×1cm) was 
covered with black tape on all the surfaces except the area for the source and detection 
fibers as shown in Figure 6.6.  Resin microspheres are densely packed in the cuvette. 
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Figure 6.6. Schematic of source and detection fibers’ position on the phantom.  The 
source fiber is located in the center of the surface with 23mm distance to the bottom of 
the cuvette.  The detection fiber moves alone the middle line on the detection surface 
from 2.8 mm to 32.3 mm in increments of 0.5 mm.   
 
 
 
6.3.3 FDPM Experiments 
The MC simulations were validated using resin measurements were conducted 
with a FDPM system previously described (159,170).  Briefly, intensity modulated light 
which is emitted from a 785 nm Laser diode (Model# DL7140-201, Thorlabs Inc., 
Newton, NJ) was directed to a beamsplitter (660-1000 nm, Newport, Irvine, CA).  A 
portion of incident light was directed to a reference PMT (R928, Hamamatsu, Japan) 
through a 1000 µm-diameter multimode optical fiber (Thorlabs, Inc.), which was 
outfitted with a band-pass filter (785nm, CVI Laser, Albuquerque, NM).  The sampling 
beam was delivered to the surface of the cubic phantom with a source fiber which 
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touched the surface perpendicularly.  The light propagated through the densely packed 
resin microspheres and was collected with a detection fiber on the detection surface 
which was 90˚ from the source fiber as shown in Figures 6.6 and 6.7.  The sample signal 
then passed through a sample PMT (R928, Hamamatsu) which is also outfitted with a 
785 band-pass filter.  Using a motion controller (ESP300, Newport), the detection fiber 
was moved on the detection surface in increments of 0.5 mm from 6 mm to 36 mm to the 
bottom side as shown in Figure 6.6.  The sample and reference PMTs were operated at 
the same modulation frequency plus an offset of 100 Hz for heterodyne detection. Two 
frequency synthesizers (Marconi Instruments, Mountain view, CA) were phase-locked 
and provided the modulation frequency for the laser diode and the reference and 
detection PMTs.  The phase-shift and modulation-ratio were taken as a function of 
modulation frequency (70-100 MHz with a step-size of 5 MHz).  Labview 7.0 (National 
Instruments, Austin, TX) was used to communicate with GPIB card (National 
instruments) and data acquisition hardware.  Six experiments were performed to collect 
the θ, AC, and DC values.  The physical meanings of the θ, AC, and DC are described in 
section 3.3.  The standard deviations of acquired θ, AC, and DC were less than 1% for 
all the measurements.  
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Figure 6.7. (Top) Schematic of FDPM instrumentation set up.  (Bottom) picture of the 
set-up for resin measurements.    
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6.4 Results and Discussions 
6.4.1 FDPM Experimental Validation of the MC Model 
Figure 6.8 and Figure 6.9 illustrate the phase-shifts (top figure) and AC (bottom 
figure) versus the detector position on the detection surface at four different modulation 
frequencies (70 MHz and 100 MHz, 80 MHz and 90 MHz) for both FDPM experimental 
and MC simulation results.  The amplitude ACs are normalized by the maximum 
amplitude AC in the elements from the element (1,5) to (10,5) at each modulation 
frequency.  That location of minimum phase shift and maximum amplitude corresponds 
to the shortest source-detector distance (7.07 mm).  If one recalls the physical meaning 
of the excitation phase shift, θx(ω), it is related to the mean “time-of-flight” <t> (171). It 
then follows that: 
( ) s dx x rt vθ ω ω ω −≈ ∝     (6.9) 
where <tx> is the mean transit time of excitation photons from the source to the detector.  
The term rs-d is separation distance between source and detection fiber.  The term v  is 
the mean speed of photon. Hence the phase shift increases with rs-d as shown in both MC 
simulation and FDPM experimental results.   
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Figure 6.8. (Top) Excitation Phase-shifts and amplitudes at different modulation 
frequency (70 MHz and 100MHz) as the function of detector position on the detection 
surface (shown in Figure 6.6).  The symbols without lines denote the FDPM experiments 
results.  The lines with symbols denote the MC simulation results.  The simulated 
amplitude AC is normalized by the maximum amplitude AC at each modulation 
frequency. 
 
 
 
 
 
  
132
 
 
 
Figure 6.9. (Top) Excitation Phase-shifts and amplitudes at different modulation 
frequency (70 MHz and 100MHz) as the function of detector position on the detection 
surface (shown in Figure 6.6).  The symbols without lines denote the FDPM experiments 
results.  The lines with symbols denote the MC simulation results.  The simulated 
amplitude AC is normalized by the maximum amplitude AC at each modulation 
frequency. 
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To evaluate the difference between MC simulation and FDPM experimental 
results, we define the phase shift deviation, δθx which is calculated as: 
∆θx = θx(FD) – θx(MC)   (6.10) 
 
where θx(FD) is the FDPM experimental results and θx(MC) is MC simulation results 
with a cubic spline interpolation scheme decided by the Matlab (Mathworks Inc. Natick, 
MA).  Figure 6.10 shows the change of δθx (degree) at different modulation frequencies 
(70-100MHz) as the function of sixty detector positions on the surface.  When detector 
position was within the range of 1.5-3.5 cm, the δθx is less than 1 degree.  Table 6.4 
demonstrates that the mean δθx values at each modulation frequency are 0.3076, 0.7856, 
0.9366, and 1.0254 degrees respectively and overall average of δθx is only 0.7638˚.  
Figure 6.11 presents the ACx deviation, δACx between the MC simulation and FDPM 
experimental results. 
δACx =[ACx(FD) – ACx(MC)]/ACx(FD)×100%  (6.11) 
When detector position was moved between 1.8 cm and 3.1 cm on the detection 
surface as shown in Figure 6.3, the δACx was less than 40%.  Table 6.4 demonstrates that 
the mean δACx values at each modulation frequency are 39.75%, 43.48%, 44.47%, 
41.46%, and 42.29% respectively and overall average of δACx is 42%.   
The differences between MC simulation and FDPM experimental results may 
result from: (i) the MC simulation model assumes the resin microspheres are 
monodisperse but in reality, as shown in Figure 6.5, the resin particle exists a normal 
size- distribution ; (ii) the MC simulation model assumes the surface of the microsphere 
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are perfectly smooth.  However, the resin is made of polystyrene divinylbenzene and is 
not perfectly smooth on the surface.  Therefore the directions for refraction and 
reflection of each photon package could be a different between the MC simulation and 
the real packing of the microsphere; (iii) the MC simulation model assumes a perfect 
uniform volume fraction within the phantom but this might not be realistic; (iv) PS and 
AC are obtained with a Fourier Transform program using a numerical integration 
method which approximates the Fourier integral (153).  
 
 
 
 
Figure 6.10. Phase shift deviation δθ (degree) at different modulation frequencies (70-
100MHz) as the function of sixty detector position on the surface.  δθ=θ(FD)-θ(MC).  
The mean δθ values at each modulation frequency are 0.3076, 0.7856, 0.9366, and 
1.0254 degree respectively.  The overall average of δθ is 0.7638 as shown in Table 6.4. 
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Figure 6.11. AC deviation δAC (%) at different modulation frequencies (70-100MHz) as 
the function of sixty detector position on the surface.  δAC=[AC(FD)-AC(MC)]/AC(FD).  
The mean δAC values at each modulation frequency are 39.75%, 43.48%, 44.47%, and 
41.46% respectively.  The overall average of δAC is 42.29% as shown in Table 6.4. 
 
 
 
Table 6.4. List of averages of δPS and δAC at different modulation frequencies. 
 Modulation frequency (MHz) 
deviation average 70 80 90 100 overall average 
δθ  (degree) 0.3076 0.7856 0.9366 1.0254 0.7638 
δAC (%) 41.75 43.48 44.47 41.46 42.29 
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6.4.2 MC Computational Results for Fluorescence  
6.4.2.1 Influence of Microsphere Size 
Figures 6.12 and 6.13 show that the fluorescence phase shift θf and ACf versus 
microsphere size ranging from 26 µm to 180 µm in the cubic phantom at different 
detection positions and different modulation frequencies.  Other simulation conditions 
are listed in Table 6.5, where fv is the volume fraction which is equal to the ratio of 
volume of packed microspheres to the total volume of the cubic phantom (4.3 cm3).  P is 
the probability for generation of fluorescence. τavg is the average of lifetime of the 
fluorophores. 
As particle diameter increases, θf decreases while ACf increases.  Under this 
simulation condition, when particle diameter changes from 26 to 100 µm, a ~27-49% 
decrease in θf occurs.  When particle size is more than 100 µm, only 5.8%~13% 
decrease in θf occurs.  Interestingly, Figure 6.14 demonstrates that θf can be described to 
be proportional to 1/sqrt(dpar).  One may recall that the isotropic scattering coefficient 
µ’s for microspheres with large particle size (dpar >>λ) is proportional to the dpar 
(172,173): 
' 1
s
pard
µ ⎛ ⎞∝ ⎜ ⎟⎜ ⎟⎝ ⎠
     (6.12) 
Our pervious FDPM experiments validated the linear relationship between µ’s 
and dpar (172).  The θf may be derived from the solution of the coupled fluorescence 
diffusion equations as: 
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( )' , , , , ,f a s a s df v r Qθ µ µ µ ω τ−∝ ⋅      (6.13) 
where v  is the mean photon speed.  The phase shift can be further related to dpar from 
equations 6.12 and 6.13: 
( )1f parsqrt dθ ∝       (6.14) 
The MC simulation results in Figure 6.14 validate the linear relationship between 
θf and 1/sqrt(dpar).  As we know from Mie theory, particles with size larger than λ will 
scatter less and hence, scattering coefficients become minimal.  Figure 6.13 illustrates 
the fluorescence amplitude ACf increases linearly with the particle diameter.   
 
 
Table 6.5. Simulation conditions for the study of particle size influence on θf  and 
amplitude ACf.  
 
 
fv P τavg  (ns) ntis npar µa, par, x (cm-1) 
µa, par,m 
(cm-1) 
0.64 0.5 1.4 1.33 1.59 0.02 0.02 
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Figure 6.12. Simulation results of fluorescence phase shift θf (radius) versus 
microsphere diameter (µm) at different detection position and different modulation 
frequencies (MHz).  The symbols represent simulation results whereas the trend lines 
connect simulation results.  The error bars denote the uncertainty in simulation for 108 
photons.  The uncertainty was calculated as the standard deviation of the simulation 
results of three data sets each containing 108 photons.  
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Figure 6.13. Simulation results of normalized fluorescence amplitude ACf (a.u) versus 
microsphere diameter (µm) at different detection positions and different modulation 
frequencies (MHz).  The simulated amplitude AC is normalized by the maximum 
amplitude AC at each modulation frequency.  The symbols represent simulation results 
whereas the solid lines are the linear fits.  The uncertainty in simulation for 108 photons 
is 2%. 
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Figure 6.14. Simulation results of fluorescence phase shift θf (radius) as a function of 
1/sqrt (dpar (in diameter, µm)) at different detection position and different modulation 
frequency (MHz). The symbols represent simulation results whereas the dotted lines are 
the linear fits.  The error bars denote the uncertainty in simulation for 108 photons. 
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6.4.2.2 Influence of Refractive Index of Microspheres 
Figures 6.15 and 6.16 illustrated θf  and ACf change as a function of refractive 
index of microspheres ranging from 1.37 to 2.4 at a modulation frequency of 100 MHz.  
The simulation conditions are listed in Table 6.6.   
 
 
Table 6.6. Simulation conditions for the study of refractive index influence on θf  and 
amplitude ACf.  
 dpar (µm) fv P 
τavg 
(ns) ntis 
µa, par, x 
(cm-1) 
µa, par,m 
(cm-1) 
frequency 
(MHz) 
1 74 0.64 0.5 1.4 1.00 0.02 0.02 100 
2 160 0.4 0.1 1.4 1.33 0.02 0.02 100 
3 26 0.2 0.1 1.4 1.33 0.02 0.02 100 
 
 
 
As the refractive index increases, the θf increases linearly while the ACf decreases 
in all three simulation cases. Under a theoretical analysis of θf, we already know from 
Equation 6.9: 
( ) -1 -1f avg avglt tan tanv
ωθ ω ω ω τ ω τ≈ + = +    (6.15) 
where <l> is the mean path length of collected fluorescence photon, which is a function 
of volume fraction, fv ,and particle diameter, dpar (161).  τavg is the average lifetime of the 
fluorophore.  
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Figure 6.15. Simulation results of fluorescence phase shift θf (radius) as a function of 
refractive index of microspheres at 100MHz and at detection position 4.  The symbols 
represent simulation results whereas the dotted lines are the linear fits.  The error bars 
denote the uncertainty in simulation for 108 photons.  The uncertainty was calculated as 
the standard deviation of the simulation results of three data sets each containing 108 
photons. 
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Figure 6.16. Simulation results of normalized fluorescence amplitude ACf (a.u.) as a 
function of refractive index of microspheres at 100MHz and at detection position 4.  The 
simulated amplitude AC is normalized by the maximum amplitude AC.  The symbols 
represent simulation results whereas the lines connecting the symbols indicate the trend 
lines.   
 
 
The mean “time-of-flight” <t> is equal to (174): 
x mt t t= +     (6.16) 
where <tx> is the mean “time-of-flight” of excitation photon which propagates from the 
source to an immobilized fluorophore inside the microsphere, and <tm> is the mean 
“time-of-flight” of fluorescence photon which propagates from the fluorophore to the 
detector. 
Then θf  can be further expanded from Equation 6.16 as: 
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where c is the light speed in vacuum.  αtis and αpar are prefactors representing the 
fractional contribution to the average speed, v  from the surrounding medium and 
microsphere, respectively.  The sum of αtis and αpar is equal to unity.  As we can see from 
Equation 6.17, there is a linear relationship between the refractive index, npar, and θf 
which can be used to explain the results in Figure 6.15.  It may be recalled that the 
higher the refractive index, a stronger scattering effect arises from the microspheres.  
Therefore the fluorescence amplitude ACf  decreases with increasing refractive index. 
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6.4.2.3 Influence of Volume Fraction  
Figures 6.17 and 6.18 present the θf  and ACf change as a function of volume 
faction of microspheres ranging from 0.1 to 0.64 at modulation frequency of 70 and 100 
MHz (in Figure 6.18).  The simulation conditions are listed in Table 6.7.   
 
 
Table 6.7. Simulation conditions for the study of volume fraction influence on θf  and 
amplitude ACf. 
 dpar (µm) P 
τavg 
(ns) ntis npar 
µa, par, x 
(cm-1) 
µa, par,m 
(cm-1) 
1 74 0.05 1.4 1.00 1.59 0.02 0.02 
 
 
When the refractive index is fixed, θf increases but ACf decreases with increasing 
volume fraction of the microspheres in the cubic phantom.  In a previous study, a 
quantitative relationship between µs’ and fv has been shown as (166): 
( )' 21 21s v v
par
a f a f
d
µ = ⋅ + ⋅     (6.18) 
where parameters a1 and a2 are decided by npar.  Accordingly, increasing fv will increase 
the isotropic scattering coefficient.  Correspondingly, the increase of θf with fv can be 
explained with Equation 6.13. 
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Figure 6.17. Simulation results of θf at different detector positions with increasing 
volume fraction of microspheres in the cubic phantom at modulation frequency of 70 
MHz.  The symbols denote the simulation results and the lines connecting the symbols 
denote the trend lines.  The error bars represent 1% simulation uncertainty for 108 
photons.  
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Figure 6.18. Simulation results of ACf at the function of volume fraction of 
microspheres in the cubic phantom at modulation frequency of 70 and 100 MHz.  The 
simulated amplitude AC is normalized by the maximum amplitude AC at each 
modulation frequency.  The symbols denote the simulation results and the lines denote 
the linear fits. The error bars represent 2% simulation uncertainty for 108 photons. 
 
 
 
6.4.2.4 Influence of Fluorescence Average Lifetime 
Figures 6.19 and 6.20 demonstrate the influence of fluorophore average lifetime 
on the θf and ACf.  The simulation conditions are listed in Table 6.8.  As the fluorophore 
average lifetime increases, θf increases and ACf decreases.  In the presence of the 
microspheres, the values of θf are magnified by the presence of the microspheres as 
shown in Figure 6.19.  It has been shown in equation 6.15 that θf consists three 
contributions from (i) “time-of-flight” of excitation photons; (ii) time-delay caused by 
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the lifetime of the excited fluorophore; and (iii) “time-of-flight” of emission photons 
(174).  For the established ConA-dextran affinity system in Section 4, the donor average 
lifetime change is from 2.79 to 3.16 ns as glucose concentration increases from 0 to 224 
mg/dL.  The corresponding ∆θf (=θf(224 mg/dL)-θf(0 mg/dL)) at 100MHz with or 
without scattering is 0.05 radiuses (=2.9˚) based on the results in Figure 6.19.  The 
presence of scattering doesn’t provide better sensitivity for ∆θf . 
 
 
 
Figure 6.19. Simulation results of fluorescence phase shift θf (radius) as a function of 
fluorophore average lifetime at 100 MHz and detection position 4.  The symbols 
represent simulation results whereas the lines connecting the symbols are the trend lines. 
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Table 6.8. Simulation conditions for the study of the influence of fluorophore lifetime 
on θf  and amplitude ACf.  
 dpar (µm) fv P ntis npar 
µa, par, x 
(cm-1) 
µa, par,m 
(cm-1) 
frequency 
(MHz) 
1 26 0.5 0.1 1.33 1.59 0.02 0.02 100 
2 74 0.5 0.5 1.33 1.59 0.02 0.02 100 
3 120 0.5 0.1 1.33 1.59 0.02 0.02 100 
4 160 0.64 0.5 1.33 1.59 0.02 0.02 100 
 
 
 
 
Figure 6.20. Simulation results of normalized fluorescence amplitude ACf (a.u.) as a 
function of fluorophore average lifetime at 100MHz modulation frequency and detection 
position 4.  The symbols represent simulation results whereas the lines connecting the 
symbols indicate the trend lines. 
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6.5 Summary 
We have shown that, a new Monte Carlo simulation for time-resolved light 
propagation at microsphere-based implantable sensors in a three-dimension cubic 
phantom.  The validity of this model for the excitation light propagation has been 
demonstrated using a single-pixel FDPM system. Comparison of experimental results 
and simulation data has shown that (i) our MC model could predict the PS and AC 
change well; (ii) the mean phase-shift deviation was 0.736˚; and (iii) the mean AC 
deviation was 42%.  The model was then applied to investigate the influence of several 
design parameters on surface detected PS and AC.  The parameters included the optical 
and physical properties of the microsphere: (i) the microsphere diameter; (ii) volume 
fraction; and (iii) refractive index. We also found that even though the sensitivity of PS 
change in presence of scattering was the same as the value without scattering, the values 
of PS were magnified due to the scattering effects.  Our work may provide, for the first 
time, a preliminary basis for designing implantable, microsphere-based optical sensors 
for lifetime measurements. 
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7. CONCLUSIONS AND FUTURE WORK 
7.1 Conclusions 
Microsphere-based implantable optical sensors are promising for future 
development of a continuous glucose sensing technique.  In this work, we tried to 
develop a new prototype of an implantable fluorescent glucose sensor using FD 
measurements.  The research was carried out into three directions:  
(i) We developed a new glucose sensitive ConA-dextran affinity system using 
long wavelength Alexa Fluor dyes.  The glucose sensing range by change of phase-shift 
could reach up to 750 mg/dL, which is within the physiological range.  For the first time, 
we analyzed the decay kinetics of this FRET system using results from FD 
measurements.  We found that parameter γ in the generalized Förster model provided 
better sensitivity for evaluating glucose concentration than the raw phase-shift data.  
Most importantly, our work extended the simple, low-cost FD instrumentation to a 
potential, powerful “weapon” for ultra-sensitive glucose sensing in the future. 
(ii) We experimentally investigated the feasibility of FD lifetime spectroscopy in 
tissue-mimicing scattering phantom with implantable microsphere-based sensor.  We 
chose a well-characterized pH sensor, C-SNAFL-1, to test the feasibility.  Following 
bioconjugation reactions and photopolymerization, self-made poly(ethylene glycol) 
microspheres encapsulating the pH fluorophores were prepared and characterized.  The 
FDPM measurements in a phantom with 0.5% polystyrene as scatters showed that: (i) 
the phase-shifts in presence of scattering were magnified compared with those in 
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absence of scattering; and (ii) the average fluorophore lifetime, τavg, which was extracted 
from measurements using optical diffusion theory, could be used to quantitatively 
measure pH change. 
(iii) A new Monte Carlo model was developed and experimentally validated for 
time-resolved light propagation in microsphere-based sensors.  The model accounted for 
the refractive index mismatch between the polymeric beads and the surrounding media.  
Geometric optics was used to trace photon tracks instead of Mie theory due to the large 
size of the microsphere compared to the wavelength of incident light.  Using this model, 
the influence of particle size, volume fraction, refractive index, and fluorophore lifetime 
on phase-shift signal was presented.  This model may provide an effective tool for future 
design of implantable microsphere-based sensors. 
7.2  Future Work 
Future work focusing on translating the FD lifetime spectroscopy into animal 
studies includes:  
(i) Designing a new FRET glucose-sensitive affinity system which either attaches 
on polymer microspheres surface or is encapsulated into polymer beads.  
(ii) Developing FD measurements in non-scattering solution that could be carried 
out to test the phase-shift response to glucose concentration change.  The glucose 
sensing range may be adjusted by changing the composition of the affinity system as 
shown in section 4.2.4.  The stability, reversibility, and time response of the system 
would be evaluated.  
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(iii) FD measurements in a tissue-mimicking scattering phantom should be 
evaluated out to show the feasibility of quantitative glucose sensing. 
Lastly, (iv) the injection of microsphere sensors into a pig skin tissue should be 
performed.  Glucose monitoring using FD lifetime spectroscopy should be examined.   
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APPENDIX 
NOMENCLATURE 
Abbreviations: 
 
3D  three dimensional 
A  acceptor 
Acryl-   α-acryloyl  
AF568  Alexa Fluor 568 
AF647  Alexa Fluor 647 
AMCA 7-amino-4-methyl-coumarin  
ANS  8-anilino-1-naphthalenesulfonic acid 
APC    Allophycocyanin 
Ar  argon 
BSGK  bacillus stearothermophilus 
CB  cascade blue 
CAD  computer-aided design 
CCD  charge-coupled device 
ConA  concanavalin A 
CQ  collisional quenching 
C-SNAFL carboxy seminaphthofluorescein 
CW  continuous wave 
Cy  cyanine 
D  donor 
DI  deionized 
DMSO  dimethyl sulfoxide 
DTTCI 3,3-diethylthiatricarbocyanine iodide 
EM  emission 
EOM  electro-optic modulator 
EtOH  ethanol 
EX  excitation 
FCC  face centered cubic 
FD  frequency-domain 
FDPM  frequency-domain photon migration 
FITC  fluorescein isothiocyanate 
FRET  fluorescence resonance energy transfer 
FWHM full width at half maximum 
GBP  glucose-binding protein 
GFP  glucose fluorescence protein 
GOX  glucose oxidase 
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Abbreviations continued: 
 
HMP  hydroxy-2-methylpropiophenone 
I-ANS  2-(4-iodoacetamidoanilino) naphthalene-6-sulfonic acid 
ICG  indocyanine green 
Kr  krypton 
LbL  layer by layer 
LPF  long pass filter 
M  modulation 
MC  Monte Carlo 
MeOH  methanol 
MG  Malachite Green 
MIMG  maltose-insulin-Malachite Green 
MLC  metal-ligand complexes 
MOPS  morpholinopropanesulfonic 
MW  molecular weight 
MWCO molecular weight cut-off 
N/A  not applicable 
NaB  sodium bicarbonate buffer 
ΝΗS  ω-N-hydroxysuccinimidyl ester 
NIR   near infrared 
OCT  optical coherence tomography 
P  probability 
PAA  polyacrylamide 
PBS  phosphate-buffered saline 
PCCA  polymerized crystalline colloidal array 
PEBBLE probes encapsulated by biologically localized embedding 
PEG  poly(ethylene glycol) 
PEG-NHS α-acryloyl ω-N-hydroxysuccinimidyl ester of PEG-propionic acid 
PEG-DA poly(ethylene glycol) diacrylate 
PET  photoninduced electron transfer 
PMT  photomultiplier tube 
PS  phase shift 
QD  quantum dot 
RCP  random close packing 
RITC  rhodamine isothiocyanate 
RF  radio frequency 
SNARF  seminaphthorhodafluor 
SNAFL seminaphthofluorescein  
SNR  signal to noise ratio 
SPR  surface plasmon resonance 
Succinyl- succinylated 
TI-Amp transimpedance amplifier 
TRITC  tetramethylrhodamine isothiocyanate. 
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Abbreviations continued: 
 
TPT  trimethylolpropane triacrylate 
UV  ultraviolet 
YFP  yellow fluorescence protein 
 
English symbols: 
ais  coefficients of orthonormal Laguerro polynomials 
aj  pre-exponential factor of a component with a lifetime τj  
A0  ground electronic state of acceptor 
A1  excited electronic state of acceptor 
AC  amplitude of intensity-modulated light [a.u.] 
[A]  acceptor concentration [mol/L] 
B  time-dependent parameter in the fractal FRET decay model 
c  light speed in vacuum [m/s] 
CA  critical acceptor concentration [mol/L] 
CD  critical donor concentration [mol/L] 
[C]  concentration [mol/L] 
[Cq]  quencher concentration [mol m-3] 
Cp  specific heat of the medium [J mol–1 K–1] 
d  minimum donor-acceptor distance 
dp  diameter of microspheres [m]  
D  optical diffusion coefficient [cm] 
Dm  optical diffusion coefficient at emission wavelength 
Dx  optical diffusion coefficient at excitation wavelength  
E  FRET efficiency 
F(ω)  Fourier transform of the FRET decay kinetics 
g  the average of the cosine of the scattering angle 
h  Planck’s constant [J s] 
i  imaginary number  
I(t)  fluorescence intensity at time t [W cm-2] 
I0  fluorescence intensity at time t=0 [W cm-2] 
IAC0  fluorescence amplitude at time t=0 [W cm-2] 
IAC  fluorescence amplitude at time t [W cm-2] 
J  overlaps of donor emission and acceptor absorption spectra 
k1  binding constant [L/mol] 
k2  binding constant [L/mol] 
K  association constant [L/mol] 
Lis  orthonomal Laguerro polynomials 
L  path length [m] 
n  refractive index 
np  refractive index of particle 
npar  refractive index of microsphere 
  
172
English symbols continued: 
 
nm  refractive index of medium 
ntis  refractive index of surrounding tissue or medium 
N(ω)  imaginary part of Fourier transform of the decay kinetics 
m  the number of frequencies for which data are measured 
MM  measured modulation [a.u.] 
MP  model predicted modulation [a.u.] 
NA  Avogadro’s number 
P(ω)  real part of Fourier transform of the decay kinetics 
Q  fluorescence quantum efficiency 
r  position [cm] 
r  spherical particle radius [m] 
r  donor-acceptor distance [m] 
rAD  collision distance [m] 
rs-d  source-detector distance [m] 
r*  interaction radius [m] 
r
r
  photon position vector 
R  Fresnel’s reflection coefficient 
R0  Förster distance [m] 
R0DD  critical energy transfer distance for donor-donor energy transfer [m] 
s  step size 
Sо  electronic ground state 
S1  excited singlet state 
Sx  excitation source term 
Sm  emission source term 
t  time [s] 
td  time delay due to the generation of fluorescence [s] 
<t>  mean “time of flight” [s]  
U(r,t)   photon density at position r and time t [W m-3] 
Ux  excitation photon density [W m-3] 
Um  emission photon density [W m-3] 
v  speed of sound in the medium [m/s] 
vE  frequency of excitation [1/s] 
w  photon weight 
 
Greek symbols: 
α  parameter related to diffusion coefficients of fluorophore and quencher 
α  parameter in the generalized Förster model 
β  thermal expansion coefficient [K-1] 
β  parameter related to diffusion coefficients of fluorophore and quencher 
β  parameter in the generalized Förster model 
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Greek symbols continued: 
 
γ  parameter in the generalized Förster model 
δθ  estimated uncertainties in the measured phase-shift [deg] 
δM  estimated uncertainties in the measured modulation-ratio  
εA  extinction coefficients [M-1 cm-1] 
φ  observed rotation 
ζm  detection efficiency factor of the instrumentation at emission wavelength 
ξaxf  extinction coefficients of fluorophore at the excitation wavelength  
θ  phase shift [degree] 
θ0  phase shift at time t=0 [degree] 
θA  angle between absorption dipole of acceptor and the joining vector 
θD  angle between emission dipole of donor and the joining vector [degree] 
θΜ  measured phase shift [degree] 
θP  model predicted phase shift [degree] 
θT angle between emission dipole of donor and absorption dipole of acceptor 
[degree] 
θi angle of incidence of photon on the boundary of particles 
θt angle of transmission of photon on the boundary of particles 
κnr  non-radiative rate of relaxation [1/s]  
κr  radiative rate of relaxation [1/s] 
κT  rate of fluorescence energy transfer [1/s] 
κq  Stern-Volmer constant [m3/s.mol] 
κ2  orientation factor 
λ  wavelength [nm] 
µa  absorption coefficient [cm-1] 
µaw  water absorption coefficient [cm-1] 
µag  intrinsic glucose absorption coefficient [cm-1] 
µax  absorption coefficient at excitation wavelength [cm-1] 
µam  absorption coefficient at emission wavelength [cm-1] 
µaxf  absorption coefficient at excitation wavelength by fluorophore [cm-1] 
µs  scattering coefficient [cm-1] 
µs’   isotropic or reduced scattering coefficient [cm-1] 
µsx’  isotropic scattering coefficient at excitation wavelength [cm-1] 
µsm’  isotropic scattering coefficient at emission wavelength [cm-1] 
∆µsg  change of scattering coefficient caused by glucose [cm-1] 
µt   total attenuation coefficient [cm-1] 
Aµ
uur    unit vector of acceptor transition moment 
Dµ
uur   unit vector of donor trabsition moment 
v
r
  photon moving direction 
ς  random number  
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Greek symbols continued: 
 
ρ(r)  probability function  
τ  fluorophore lifetime [s] 
τ0  unquenched fluorophore lifetime [s] 
τavg  fluorophore average lifetime [s] 
τavgscat  fluorophore average lifetime at presence of scattering 
τj  lifetime of fluorescent component j [s] 
τF  donor lifetime [s] 
Φ  light fluence [W/cm2] 
ρP  volume density [m-3] 
χ2 the error- weighted sum of squared deviations between the measured and  
calculated values of phase delay and amplitude demodulation 
ω  angular modulation frequency [rad/sec] 
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